FeatureID,Name,Formula,MW,KEGG Pathways,Metabolika Pathways,name4plot,C,H,N,O,S,P,F,Cl,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,control_means,treatment_means,ratio,log2FC,pval,pval.adj,Comment
Feature0342,NA,C8 H16 N2 O9,284.08565,NA,NA,Feature0342,8,16,2,9,0,0,0,0,2,1.125,1,31.799999999999997,2,-7,3,-3,-9,Carbohydrate,2376674.2324166126,2746893.6832675133,1.1557720640890947,0.20885690438486648,0.8181746803458949,0.875875171257202,Upregulated
Feature0341,3-Deoxytetronic acid,C4 H8 O4,120.04228,NA,NA,3-Deoxytetronic acid,4,8,0,4,0,0,0,0,2,1,0,60.3,1,-3,-Inf,-0.5,-3,Carbohydrate,1801418.6861192132,2347505.1077997033,1.3031424209642908,0.38199476524951714,0.5054245907369612,0.6107957951662216,Upregulated
Feature0340,6-Deoxy-D-arabino-hexos-2-ulose,C6 H10 O5,162.05281,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Fructose and mannose metabolism;Other,Superpathway of butirocin biosynthesis;Other,6-Deoxy-D-arabino-hexos-2-ulose,6,10,0,5,0,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,2273796.061721057,807318.387303582,0.3550531205918772,-1.4938932080693401,0.3148566484125824,0.45244106620631586,Downregulated
Feature0339,Oleic acid,C18 H34 O2,282.2559,Biosynthesis of plant secondary metabolites;Other,Other,Oleic acid,18,34,0,2,0,0,0,0,1.8888888888888888,0.1111111111111111,-1.666666666666667,107.8,2,0,0,0.0588235294117647,0,Lipid,1105967.7087129063,2889407.4979233732,2.612560452859861,1.3854644205550795,0.0032764491978539375,0.15566454572065455,Upregulated
Feature0338,DL-TYROSINE,C9 H11 N O3,181.07387,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Central carbon metabolism in cancer;Other,Superpathway of chorismate metabolism;Superpathway of betalain biosynthesis;Other,DL-TYROSINE,9,11,1,3,0,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,4351198.0235445,4546161.309187977,1.0448068059850466,0.063236199899828,0.7836316492496963,0.8701364416993381,Upregulated
Feature0337,Mevalonic acid,C6 H12 O4,148.07361,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Biosynthesis of terpenoids and steroids;Other,Superpathway of branched chain amino acid biosynthesis;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of L-threonine metabolism;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of L-isoleucine biosynthesis I;Other,Mevalonic acid-peak2,6,12,0,4,0,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,1844531.7005040515,147842.873228512,0.08015198285185951,-3.6411179786255947,0.40838058836656543,0.5340653755448862,Downregulated
Feature0336,MFCD01318772,C8 H13 N3 O2,183.10073,NA,NA,MFCD01318772,8,13,3,2,0,0,0,0,1.625,0.25,0,60.3,4,2,-0.3333333333333333,0,-1,Lipid,5362443.899385546,2612060.7048085467,0.4871026632293251,-1.0377022237655884,0.006040728450707661,0.15566454572065455,Downregulated
Feature0335,Leu-arg,C12 H25 N5 O3,287.19584,NA,NA,Leu-arg,12,25,5,3,0,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,654940.1643358817,940054.4389172423,1.4353287370464909,0.521381198915771,0.16043235427015018,0.33253251612358403,Upregulated
Feature0334,Ser-Leu,C9 H18 N2 O4,218.12657,Other,NA,Ser-Leu,9,18,2,4,0,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,1010626.0780687347,4707655.50660075,4.65815756070424,2.2197594390769506,0.0019236078555081976,0.15434581914546944,Upregulated
Feature0333,beta-D-Ethyl glucuronide,C8 H14 O7,222.07387,NA,NA,beta-D-Ethyl glucuronide-peak5,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,70979.56610889004,126662.24124491068,1.7844888069701303,0.8355108522531003,0.029573383834477135,0.17078205932289886,Upregulated
Feature0332,NA,C8 H11 N O5,201.06375,NA,NA,Feature0332,8,11,1,5,0,0,0,0,1.375,0.625,0.25,53.175,4,-1,-1,0.1111111111111111,-2,Lignin,3319624.009788627,1864048.5618370266,0.5615240028209453,-0.8325804017171994,0.4106993969833482,0.5340653755448862,Downregulated
Feature0331,NA,C9 H13 N O4 S,231.05648,NA,NA,Feature0331,9,13,1,4,1,0,0,0,1.4444444444444444,0.4444444444444444,0,60.3,4,0,-0.6666666666666666,0,-2,Lignin,790819.409824469,1664898.0404438768,2.1052822171036736,1.074013642282109,0.17671540635576147,0.34471932508735253,Upregulated
Feature0330,"8-Azabicyclo[3.2.1]octane-1,2,3,4-tetrol",C7 H13 N O4,175.08438,NA,NA,"8-Azabicyclo[3.2.1]octane-1,2,3,4-tetrol",7,13,1,4,0,0,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,387654.463108267,135383.04782393767,0.3492363966054143,-1.5177241737612241,0.12378331760300523,0.2965243003787072,Downregulated
Feature0329,NA,C21 H36 N2 O6 S4,540.14577,NA,NA,Feature0329,21,36,2,6,4,0,0,0,1.7142857142857142,0.2857142857142857,-0.4761904761904763,73.87142857142857,5,-1,-0.7777777777777778,-0.3333333333333333,-7,Lipid,119326.64182731233,116561.87472283977,0.976830261355434,-0.03382020042694562,0.8743428589070961,0.9033995702302927,Downregulated
Feature0328,3-methoxyanthranilic acid,C8 H9 N O3,167.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,3-methoxyanthranilic acid,8,9,1,3,0,0,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,1300068.1402222952,1327932.1168455868,1.0214327047646343,0.03059415786413975,0.931957532989087,0.9552565448451726,Upregulated
Feature0327,cis-trihomoaconitic acid,C9 H12 O6,216.0633,Metabolic pathways;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Other,NA,cis-trihomoaconitic acid-peak2,9,12,0,6,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,4,-2,-0.6666666666666666,0.16666666666666666,-2,Tannin,417511.89928004233,264232.172365884,0.6328733931213124,-0.660011178780294,0.15656891997962796,0.3285065683008145,Downregulated
Feature0326,asp-leu,C10 H18 N2 O5,246.12159,Metabolic pathways;Other,NA,asp-leu-peak2,10,18,2,5,0,0,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,466002.8799981958,305637.9417078173,0.6558713579388192,-0.6085152212991607,0.7102781782045671,0.8092659958559845,Downregulated
Feature0325,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one",C8 H10 O5,186.05284,NA,NA,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one-peak3",8,10,0,5,0,0,0,0,1.25,0.625,0,60.3,4,-1,-0.3333333333333333,0.2727272727272727,-1,Lignin,2484753.1143332995,3527094.4744126596,1.4194949405905213,0.5053777069714467,0.4924447825710578,0.5993456072573017,Upregulated
Feature0324,NA,C13 H11 N7 O4 S,361.05925,NA,NA,Feature0324,13,11,7,4,1,0,0,0,0.8461538461538461,0.3076923076923077,1.5384615384615383,16.453846153846158,12,8,0,0.6666666666666666,0,Lignin,115480.54733430364,87303.54183717203,0.7560021480019293,-0.40353776135724606,0.42424797476754317,0.5434187541966283,Downregulated
Feature0323,4-Undecylbenzenesulfonic acid,C17 H28 O3 S,312.17604,NA,NA,4-Undecylbenzenesulfonic acid-peak2,17,28,0,3,1,0,0,0,1.6470588235294117,0.17647058823529413,-1.1764705882352944,93.8294117647059,4,1,0,0.10344827586206896,0,Lipid,3768488.64467401,4658542.1525537,1.2361831470920308,0.3058925020022081,0.15172498321719982,0.3222977904365362,Upregulated
Feature0322,Genipin,C11 H14 O5,226.0841,NA,NA,Genipin,11,14,0,5,0,0,0,0,1.2727272727272727,0.4545454545454546,-0.3636363636363633,70.66363636363636,5,0,0,0.29411764705882354,0,Lignin,94105.8015672571,313274.9309677667,3.3289651195826657,1.7350737542063996,0.06944412201528913,0.2199063863817489,Upregulated
Feature0321,Ro 20-1724,C15 H22 N2 O3,278.16312,NA,NA,Ro 20-1724,15,22,2,3,0,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,232800.15686752534,1429244.7052621231,6.139363153760387,2.618089010226877,0.1447280601234459,0.31722272091709075,Upregulated
Feature0320,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.074,NA,NA,Phenyl D-glucopyranosiduronic acid,12,14,0,7,0,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,2356008.7261747867,1862071.9666332998,0.7903501994479273,-0.33943605038510066,0.14902226762929613,0.3198601445549503,Downregulated
Feature0319,NA,C6 H12 O8 S,244.02539,NA,NA,Feature0319,6,12,0,8,1,0,0,0,2,1.3333333333333333,1,31.799999999999997,1,-7,2.6666666666666665,-4,-8,Carbohydrate,1550487.113267174,1526881.1043035176,0.984775101475101,-0.022133808930646863,0.9741801723928929,0.9828012358653964,Downregulated
Feature0318,NA,C7 H16 O6,196.09468,NA,NA,Feature0318,7,16,0,6,0,0,0,0,2.2857142857142856,0.8571428571428571,-0.5714285714285712,76.58571428571427,0,-6,-6,-0.75,-6,Carbohydrate,93176.9942320604,348148.967181406,3.736426250393197,1.9016590466563785,0.25437791543674537,0.3967724785698909,Upregulated
Feature0317,"2,2-Bis(hydroxymethyl)propionic acid",C5 H10 O4,134.05797,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis,"2,2-Bis(hydroxymethyl)propionic acid",5,10,0,4,0,0,0,0,2,0.8,-0.4000000000000003,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,6153790.278143817,3545861.901791333,0.5762077908935305,-0.7953389276081263,0.019052780136216408,0.16912126459608967,Downregulated
Feature0316,Adipic acid,C6 H10 O4,146.05797,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of L-isoleucine biosynthesis I;Other,Adipic acid,6,10,0,4,0,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,185970.51543169733,227010.16069721564,1.2206782358496566,0.28768296386343706,0.22957229518040154,0.37535912016174644,Upregulated
Feature0315,D-(+)-Mannose,C6 H12 O6,180.06334,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Galactose metabolism;Carbon metabolism;Biosynthesis of phenylpropanoids;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of scopolin and esculin biosynthesis;Homolactic fermentation;Superpathway of CMP-sialic acids biosynthesis;Superpathway of betalain biosynthesis;Other,D-(+)-Mannose,6,12,0,6,0,0,0,0,2,1,0,60.3,1,-5,-Inf,-0.6666666666666666,-5,Carbohydrate,201399.409967367,228208.915366422,1.133116106960785,0.18029569730519013,0.8064559748305665,0.875875171257202,Upregulated
Feature0314,N-(2-Hydroxyethyl)glutamine,C7 H14 N2 O4,190.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,Other,N-(2-Hydroxyethyl)glutamine,7,14,2,4,0,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,1988540.0024647533,3602564.8435132997,1.81166324994619,0.8573148136719972,0.026353920561129805,0.16912126459608967,Upregulated
Feature0313,Glycyl-L-leucine,C8 H16 N2 O3,188.11609,Metabolic pathways;Other,Superpathway of L-lysine degradation,Glycyl-L-leucine,8,16,2,3,0,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,1602575.5730328134,3694907.058614523,2.3056055020369817,1.2051456834393148,0.030960490286607394,0.17078205932289886,Upregulated
Feature0312,NA,C12 H9 N5 O7 S,367.02222,NA,NA,Feature0312,12,9,5,7,1,0,0,0,0.75,0.5833333333333334,1.8333333333333337,8.04999999999999,11,4,2,0.6,-2,Condensed HC,5385616.623597844,7063180.92534725,1.3114897362725226,0.39120651710600507,0.22798002779657242,0.37535912016174644,Upregulated
Feature0311,NA,C28 H43 O4 P,474.28996,NA,NA,Feature0311,28,43,0,4,0,1,0,0,1.5357142857142858,0.14285714285714285,-1.4285714285714288,101.01428571428572,8,4,0.13043478260869565,0.2,3,Lipid,7560752.89015067,11850285.174894128,1.567341949547299,0.6483199692789181,0.07698025760929406,0.23718241533674386,Upregulated
Feature0310,NA,C8 H11 O4 P S,234.01153,NA,NA,Feature0310,8,11,0,4,1,1,0,0,1.375,0.5,-0.75,81.675,4,0,-1,0,-2,Lignin,352682.4630387557,394266.67278781766,1.1179083569700836,0.16080192488604958,0.7997444532763844,0.875875171257202,Upregulated
Feature0309,(E)-Ferulic acid,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,Superpathway of scopolin and esculin biosynthesis;Other,(E)-Ferulic acid,10,10,0,4,0,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,1857463.9405484777,13383305.18662678,7.205149394542172,2.8490283441447364,0.017757660677048565,0.16912126459608967,Upregulated
Feature0308,3-Hydroxybutyric acid,C4 H8 O3,104.04735,Metabolic pathways;Microbial metabolism in diverse environments;Carbon metabolism;Other,NA,3-Hydroxybutyric acid-peak3,4,8,0,3,0,0,0,0,2,0.75,-0.5,74.55,1,-2,-2,-0.2,-2,Carbohydrate,2632593.144169407,453279.72465700534,0.1721799381195368,-2.538011040779637,0.4299670997019484,0.5475958867974121,Downregulated
Feature0307,"2,4-Dihydroxybenzoic acid",C7 H6 O4,154.02667,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of phenylpropanoids;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Other,"2,4-Dihydroxybenzoic acid",7,6,0,4,0,0,0,0,0.8571428571428571,0.5714285714285714,0.2857142857142856,52.15714285714286,5,1,0.3333333333333333,0.6,1,Lignin,6280809.63329692,5637701.960490444,0.8976075203112156,-0.1558433317411835,0.27061848439484104,0.40952000735856475,Downregulated
Feature0306,NA,C12 H17 N O4,239.11571,NA,NA,Feature0306,12,17,1,4,0,0,0,0,1.4166666666666667,0.3333333333333333,-0.5,74.55,5,1,0,0.2222222222222222,0,Lignin,6698600.760286267,5954150.6051315935,0.8888648268802246,-0.1699640553790506,0.4752153900136716,0.586728026659479,Downregulated
Feature0305,6-Deoxy-3-O-methyl-beta-D-galactopyranose,C7 H14 O5,178.08407,NA,NA,6-Deoxy-3-O-methyl-beta-D-galactopyranose-peak2,7,14,0,5,0,0,0,0,2,0.7142857142857143,-0.5714285714285712,76.58571428571427,1,-4,-2,-0.3333333333333333,-4,Carbohydrate,129500.48184312003,238106.31518349334,1.8386519632563298,0.8786484191717124,0.022685271198377696,0.16912126459608967,Upregulated
Feature0304,NA,C6 H7 N3 O5 P2,262.98597,NA,NA,Feature0304,6,7,3,5,0,2,0,0,1.1666666666666667,0.8333333333333334,0.3333333333333335,50.8,6,1,1,1,-4,Tannin,175984.162795565,323323.412659979,1.8372301661915633,0.8775323770329567,0.022834166926172055,0.16912126459608967,Upregulated
Feature0303,diphthinate,C13 H22 N4 O4,298.16421,NA,NA,diphthinate,13,22,4,4,0,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,76987.11451832496,133311.54404837667,1.731608528030298,0.7921128108354175,0.014526372401716343,0.16912126459608967,Upregulated
Feature0302,NA,C3 H9 N4 O2 P,164.04635,NA,NA,Feature0302,3,9,4,2,0,1,0,0,3,0.6666666666666666,0.6666666666666665,41.3,2,0,1.25,1.3333333333333333,-5,Other,838010.8616265063,202601.15783203984,0.2417643578495016,-2.0483265241793207,0.4565088709030405,0.5677310321775995,Downregulated
Feature0301,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one",C8 H10 O5,186.05281,NA,NA,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one-peak2",8,10,0,5,0,0,0,0,1.25,0.625,0,60.3,4,-1,-0.3333333333333333,0.2727272727272727,-1,Lignin,770065.0148386477,3303401.3509551203,4.289769418556542,2.1009001028191596,0.04249325676977621,0.18042689182236984,Upregulated
Feature0300,DL-Nordihydroguaiaretic acid,C18 H22 O4,302.1519,NA,NA,DL-Nordihydroguaiaretic acid,18,22,0,4,0,0,0,0,1.2222222222222223,0.2222222222222222,-0.7777777777777777,82.46666666666667,8,4,0.2857142857142857,0.375,4,Lignin,375528.069147123,18669363.04346157,49.71496028475931,5.635608149509862,0.06660967852655954,0.21430332881038902,Upregulated
Feature0299,N-Acetyl-Î±-D-glucosamine 1-phosphate,C8 H16 N O9 P,301.05637,Metabolic pathways;Galactose metabolism;Phosphotransferase system (PTS);Other,Chitin biosynthesis;Superpathway of CMP-sialic acids biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,N-Acetyl-Î±-D-glucosamine 1-phosphate,8,16,1,9,0,1,0,0,2,1.125,0,60.3,2,-7,3,-3,-9,Carbohydrate,2777051.057463753,2758286.7296480834,0.9932430742440843,-0.009781266265455103,0.9840942438836682,0.9898830335535721,Downregulated
Feature0298,3-O-methylgallic acid,C8 H8 O5,184.03711,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,3-O-methylgallic acid,8,8,0,5,0,0,0,0,1,0.625,0.25,53.175,5,0,0,0.4545454545454546,0,Lignin,311567.802377776,333672.310166683,1.0709460593174684,0.0988858172357423,0.8461728660705257,0.8849881351563296,Upregulated
Feature0297,Wikstromol,C20 H22 O7,374.13667,NA,NA,Wikstromol,20,22,0,7,0,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Lignin,64833.63844544693,104286.72402012956,1.6085280191066202,0.6857410666553098,0.06704811749330884,0.21430332881038902,Upregulated
Feature0296,Propyl gallate,C10 H12 O5,212.06837,NA,NA,Propyl gallate,10,12,0,5,0,0,0,0,1.2,0.5,-0.20000000000000015,66,5,0,0,0.3333333333333333,0,Lignin,199532.83501104,269549.3202654263,1.3509020720850897,0.4339230963972516,0.3866360809384655,0.5205887389013985,Upregulated
Feature0295,D-Sedoheptulose 7-phosphate,C7 H15 O10 P,290.04036,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Biosynthesis of amino acids;Other,Other,D-Sedoheptulose 7-phosphate,7,15,0,10,0,1,0,0,2.142857142857143,1.4285714285714286,0,60.3,1,-9,2.5,-5,-10,Carbohydrate,2187179.8490146734,863489.9930762127,0.394796062822733,-1.3408204925663072,0.02142029740550002,0.16912126459608967,Downregulated
Feature0294,Acetyl-L-methionine,C7 H13 N O3 S,191.06167,NA,NA,Acetyl-L-methionine,7,13,1,3,1,0,0,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,972974.6016110013,126272.84004629166,0.1297802017002454,-2.9458577815613696,0.39158914765470104,0.5225915546166897,Downregulated
Feature0293,Dodecyl sulfate,C12 H26 O4 S,266.15528,NA,NA,Dodecyl sulfate-peak2,12,26,0,4,1,0,0,0,2.1666666666666665,0.3333333333333333,-1.333333333333333,98.29999999999998,0,-4,-0.7142857142857143,-0.3333333333333333,-5,Protein,4615100.788007277,6467376.621013137,1.4013511119451936,0.4868184718275997,0.013510629281642199,0.16912126459608967,Upregulated
Feature0292,Glycolic acid,C2 H4 O3,76.01607,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Other,Other,Glycolic acid-peak2,2,4,0,3,0,0,0,0,2,1.5,1,31.799999999999997,1,-2,2,-1,-2,Carbohydrate,2255536.037007308,3731293.08745141,1.654282186686836,0.7262053497507042,0.4342056788648824,0.5475958867974121,Upregulated
Feature0291,NA,C12 H22 N6 O7 P2 S2,488.04681,NA,NA,Feature0291,12,22,6,7,2,2,0,0,1.8333333333333333,0.5833333333333334,0.3333333333333335,50.8,6,-1,2.2,5,-11,Amino Sugar,3542369.60473187,2074801.5715382334,0.5857100763191762,-0.7717413806846642,0.3848600643628006,0.520245620601098,Downregulated
Feature0290,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid,C9 H8 O6 S,244.00407,NA,NA,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid-peak3,9,8,0,6,1,0,0,0,0.8888888888888888,0.6666666666666666,0.6666666666666665,41.3,6,0,-0.5,0.4,-1,Tannin,158118.82784685466,297121.13718190766,1.8791003021454415,0.9100420766279662,0.1494684055746268,0.3198601445549503,Upregulated
Feature0289,NA,C23 H51 N6 O15 P S3,778.23108,NA,NA,Feature0289,23,51,6,15,3,1,0,0,2.217391304347826,0.6521739130434783,-0.08695652173913082,62.77826086956522,2,-13,11.5,-2.8181818181818183,-23,Other,119895.82787336447,190809.69526341566,1.5914623440020894,0.670353021401008,0.04758203741448338,0.18284333478374512,Upregulated
Feature0288,"N'-(2-Thienylcarbonyl)-2,5-bis(2,2,2-trifluoroethoxy)benzohydrazide",C16 H12 F6 N2 O4 S,442.04207,NA,NA,"N'-(2-Thienylcarbonyl)-2,5-bis(2,2,2-trifluoroethoxy)benzohydrazide",16,12,2,4,1,0,6,0,0.75,0.25,0.25,53.175,12,8,0.5555555555555556,0.6363636363636364,5,Condensed HC,106455.5792854249,114624.90990960666,1.076739337468433,0.10666903720170828,0.8220551868957798,0.875875171257202,Upregulated
Feature0287,"(1S,2S,3R,4S,5R,6S)-2,3,4,6-Tetrahydroxy-5-methoxycyclohexyl 6-O-alpha-D-galactopyranosyl-alpha-D-galactopyranoside",C19 H34 O16,518.18462,NA,NA,"(1S,2S,3R,4S,5R,6S)-2,3,4,6-Tetrahydroxy-5-methoxycyclohexyl 6-O-alpha-D-galactopyranosyl-alpha-D-galactopyranoside",19,34,0,16,0,0,0,0,1.7894736842105263,0.8421052631578947,-0.10526315789473716,63.3,3,-13,-4.333333333333333,-0.4545454545454546,-13,Carbohydrate,114085.84174464093,201201.65084713133,1.7635987758891438,0.8185223806945163,0.03287467645794675,0.17252933836885667,Upregulated
Feature0286,(-)-Shikimic acid,C7 H10 O5,174.05278,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Other,(-)-Shikimic acid-peak2,7,10,0,5,0,0,0,0,1.4285714285714286,0.7142857142857143,0,60.3,3,-2,-1,0.1111111111111111,-2,Tannin,927468.2663929173,956080.0181490147,1.030849305353997,0.043833447828742024,0.9358602557886171,0.9554155447155435,Upregulated
Feature0285,"2,3-Dihydroxypropyl beta-D-galactopyranoside",C9 H18 O8,254.10022,Galactose metabolism;Other,NA,"2,3-Dihydroxypropyl beta-D-galactopyranoside",9,18,0,8,0,0,0,0,2,0.8888888888888888,-0.22222222222222232,66.63333333333333,1,-7,-7,-0.6,-7,Carbohydrate,4722665.87058022,203891.96272530066,0.043173065449207994,-4.5337246565917715,0.01597776236186392,0.16912126459608967,Downregulated
Feature0284,NA,C31 H27 N2 O10 P,618.14042,NA,NA,Feature0284,31,27,2,10,0,1,0,0,0.8709677419354839,0.3225806451612903,-0.193548387096774,65.81612903225806,20,10,0.3888888888888889,0.5217391304347826,7,Lignin,30160.339919445836,49726.45538095163,1.6487365697390755,0.7213609076346675,0.05583892738535231,0.1989261788103176,Upregulated
Feature0283,NA,C2 H5 N O4 S4,234.91002,NA,NA,Feature0283,2,5,1,4,4,0,0,0,2.5,2,7,-139.2,1,-3,1.1428571428571428,1.2,-8,Other,148053.0698634783,206116.59402309134,1.392180481047466,0.4773462530212428,0.19898421198387242,0.35949979306502305,Upregulated
Feature0282,D-Glucono-delta-lactone,C6 H10 O6,178.04779,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Galactose metabolism;Carbon metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,D-Glucono-delta-lactone-peak2,6,10,0,6,0,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,2932428.9543203874,748392.75300053,0.2552125779204003,-1.9702286621159995,0.2589650178830148,0.39818254000503933,Downregulated
Feature0281,NA,C12 H10 N2 O7 S,326.02086,NA,NA,Feature0281,12,10,2,7,1,0,0,0,0.8333333333333334,0.5833333333333334,1,31.799999999999997,9,2,-0.5,0.4545454545454546,-1,Lignin,2886633.087695404,796296.715684651,0.27585657459514157,-1.8580097297044678,0.3139884183958546,0.45244106620631586,Downregulated
Feature0280,NA,C17 H33 N O8 S2,443.16496,NA,NA,Feature0280,17,33,1,8,2,0,0,0,1.9411764705882353,0.4705882352941176,-0.5882352941176467,77.06470588235292,2,-6,-1.5,-0.5,-9,Protein,646260.7309730316,189104.19547889035,0.29261285177295054,-1.7729349597857915,0.0369567072305354,0.17252933836885667,Downregulated
Feature0279,NA,C16 H28 O14,444.14812,NA,NA,Feature0279,16,28,0,14,0,0,0,0,1.75,0.875,0,60.3,3,-11,-5.5,-0.4444444444444444,-11,Carbohydrate,136054.76428039547,135889.283555511,0.9987837197340372,-0.0017557894906721336,0.9956613195629721,0.9983440877807055,Downregulated
Feature0278,Phloroacetophenone,C8 H8 O4,168.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Phloroacetophenone,8,8,0,4,0,0,0,0,1,0.5,0,60.3,5,1,0.25,0.5,1,Lignin,1230788.697231211,4274759.034389833,3.4731867817817585,1.796259998368826,0.07697038865486705,0.23718241533674386,Upregulated
Feature0277,Dodecyl sulfate,C12 H26 O4 S,266.15522,NA,NA,Dodecyl sulfate-peak1,12,26,0,4,1,0,0,0,2.1666666666666665,0.3333333333333333,-1.333333333333333,98.29999999999998,0,-4,-0.7142857142857143,-0.3333333333333333,-5,Protein,1263872.9658929268,2735326.4341951064,2.1642415875733185,1.1138615517248855,0.009503823297771117,0.16912126459608967,Upregulated
Feature0276,2-(Benzoyloxy)-3-hydroxysuccinic acid,C11 H10 O7,254.04268,NA,NA,2-(Benzoyloxy)-3-hydroxysuccinic acid,11,10,0,7,0,0,0,0,0.9090909090909092,0.6363636363636364,0.36363636363636376,49.93636363636363,7,0,0,0.4666666666666667,0,Lignin,416885.5591521443,711769.12962275,1.707348969032018,0.7717579643042272,0.17483424649153798,0.34471932508735253,Upregulated
Feature0275,trans-Aconitic acid,C6 H6 O6,174.01637,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Other,Superpathway of betalain biosynthesis;Other,trans-Aconitic acid,6,6,0,6,0,0,0,0,1,1,1,31.799999999999997,4,-2,-Inf,0.3333333333333333,-2,Tannin,1096563.5950932098,153872.274593588,0.14032225333954168,-2.8331842745485196,0.4398171619512193,0.5489688663770693,Downregulated
Feature0274,NA,C50 H80 O5 P2 S,854.52014,NA,NA,Feature0274,50,80,0,5,1,2,0,0,1.6,0.1,-1.5599999999999996,104.76,12,7,0.09523809523809525,0.14606741573033707,4,Lipid,605285.2628935985,55297.89800628211,0.09135840800406662,-3.4523186790110265,0.18592199207432927,0.34936989719461875,Downregulated
Feature0273,leu-gln,C11 H21 N3 O4,259.15323,NA,NA,leu-gln-peak2,11,21,3,4,0,0,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,325191.30884040083,954470.186551824,2.9351036162539756,1.553411434857343,0.03538524479078965,0.17252933836885667,Upregulated
Feature0272,"N-acetyl-LL-2,6-diaminopimelic acid",C9 H16 N2 O5,232.10586,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,"N-acetyl-LL-2,6-diaminopimelic acid",9,16,2,5,0,0,0,0,1.7777777777777777,0.5555555555555556,0,60.3,3,-2,-2,-0.3333333333333333,-4,Amino Sugar,574832.6852666116,1558137.6137291268,2.710593279862733,1.4386086553574606,0.0022565178237641727,0.15434581914546944,Upregulated
Feature0271,NA,C11 H9 N S,187.04563,NA,NA,Feature0271,11,9,1,0,1,0,0,0,0.8181818181818182,0,-0.3636363636363633,70.66363636363636,8,8,0.6666666666666666,0.6666666666666666,6,Unsaturated HC,2557193.8757680636,4248302.888672456,1.6613143527869827,0.7323250849181346,0.02161990683583027,0.16912126459608967,Upregulated
Feature0270,leu-gln,C11 H21 N3 O4,259.15324,NA,NA,leu-gln-peak1,11,21,3,4,0,0,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,817660.836268218,1951798.1130589866,2.3870509953331513,1.255229387504056,0.0054636903310838845,0.15566454572065455,Upregulated
Feature0269,Gly-Phe,C11 H14 N2 O3,222.10048,NA,NA,Gly-Phe,11,14,2,3,0,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Lignin,713927.4168880653,955425.836712519,1.3382674682492515,0.42036648410599275,0.09375498412756574,0.25931792540325765,Upregulated
Feature0268,3-formylsalicylic acid,C8 H6 O4,166.02653,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate,3-formylsalicylic acid,8,6,0,4,0,0,0,0,0.75,0.5,0.25,53.175,6,2,0.5,0.6666666666666666,2,Condensed HC,1142611.4144399571,1063699.7022781726,0.9309374025460243,-0.10324393255184766,0.8295124228755698,0.875875171257202,Downregulated
Feature0267,NA,C9 H22 N O8 P,303.10844,NA,NA,Feature0267,9,22,1,8,0,1,0,0,2.4444444444444446,0.8888888888888888,-0.8888888888888893,85.63333333333334,0,-8,10,-2,-10,Carbohydrate,37388027.01121357,15114575.283883434,0.4042624468884172,-1.3066359011816226,0.12611253600673009,0.29745163665035645,Downregulated
Feature0266,Gly-thr,C6 H12 N2 O4,176.0797,Other,NA,Gly-thr,6,12,2,4,0,0,0,0,2,0.6666666666666666,0.3333333333333335,50.8,2,-2,-Inf,-1,-4,Amino Sugar,579982.3698930154,1542677.3438885265,2.6598693752934106,1.4113553975145419,0.004140787690671339,0.15566454572065455,Upregulated
Feature0265,NA,C9 H24 N6 O P2,294.14866,NA,NA,Feature0265,9,24,6,1,0,2,0,0,2.6666666666666665,0.1111111111111111,-1.5555555555555554,104.63333333333333,2,1,-Inf,-13,-7,Other,1051939.5718544982,226928.67783391633,0.21572406239443626,-2.212740987647356,0.09310729868626481,0.25931792540325765,Downregulated
Feature0264,NA,C7 H17 N O10,275.08534,NA,NA,Feature0264,7,17,1,10,0,0,0,0,2.4285714285714284,1.4285714285714286,0.8571428571428572,35.87142857142857,0,-10,2.75,-6,-11,Carbohydrate,722368.2529761629,428966.193632878,0.593833120247926,-0.7518705349327655,0.07135102663889219,0.2238720285367076,Downregulated
Feature0263,D-Glucosamine 6-phosphate,C6 H14 N O8 P,259.04576,Metabolic pathways;Biosynthesis of secondary metabolites;Galactose metabolism;Phosphotransferase system (PTS);Other,Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,D-Glucosamine 6-phosphate,6,14,1,8,0,1,0,0,2.3333333333333335,1.3333333333333333,0,60.3,1,-7,2.25,-Inf,-9,Carbohydrate,690845.9157738787,615799.5803831217,0.8913703711967511,-0.16590308775991128,0.5274623669043526,0.630291535920109,Downregulated
Feature0262,Luteolin,C15 H10 O6,286.04782,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,Other,Luteolin,15,10,0,6,0,0,0,0,0.6666666666666666,0.4,0.1333333333333333,56.5,11,5,0.5555555555555556,0.6666666666666666,5,Condensed HC,30251.830529707033,85558.51911875047,2.8282096527921756,1.4998890698759413,0.24755269512350878,0.3883624850102752,Upregulated
Feature0261,NA,C7 H7 N3 O4 P2,258.99119,NA,NA,Feature0261,7,7,3,4,0,2,0,0,1,0.5714285714285714,0,60.3,7,3,1,NA,-2,Lignin,467006.2493762217,152787.42347377233,0.3271635522604887,-1.6119160614669474,0.2804884647651995,0.42258614515285564,Downregulated
Feature0260,Abietin,C16 H22 O8,342.13151,Biosynthesis of secondary metabolites;Other,NA,Abietin,16,22,0,8,0,0,0,0,1.375,0.5,-0.375,70.9875,6,-2,-0.25,0.16666666666666666,-2,Lignin,79760.60326848106,93440.21703622966,1.1715084039886439,0.2283673036242256,0.3525290849556287,0.48811719455394736,Upregulated
Feature0259,2-Aminomuconic acid,C6 H7 N O4,157.03757,Metabolic pathways;Other,Other,2-Aminomuconic acid,6,7,1,4,0,0,0,0,1.1666666666666667,0.6666666666666666,0.6666666666666665,41.3,4,0,-1,0.3333333333333333,-1,Tannin,897734.6886840783,1409961.3227070132,1.570576853584403,0.651294540616286,0.036581909159933985,0.17252933836885667,Upregulated
Feature0258,3653579,C18 H24 O5,320.16251,NA,NA,3653579,18,24,0,5,0,0,0,0,1.3333333333333333,0.2777777777777778,-0.7777777777777777,82.46666666666667,7,2,0.15384615384615383,0.2903225806451613,2,Lignin,391061.7928536833,27418493.0306691,70.11294258789377,6.131608879834453,0.10135653361296407,0.26686502690663877,Upregulated
Feature0257,"2-Hydroxy-3,4,5-trimethoxybenzoic acid",C10 H12 O6,228.06339,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"2-Hydroxy-3,4,5-trimethoxybenzoic acid",10,12,0,6,0,0,0,0,1.2,0.6,0,60.3,5,-1,-0.25,0.2857142857142857,-1,Lignin,477923.2955118883,83752.06533873614,0.17524164677729717,-2.512582417785185,0.3922848616569668,0.5225915546166897,Downregulated
Feature0256,NA,C14 H22 O10,350.12144,NA,NA,Feature0256,14,22,0,10,0,0,0,0,1.5714285714285714,0.7142857142857143,-0.14285714285714324,64.37142857142858,4,-6,-1.5,-0.1111111111111111,-6,Carbohydrate,686370.7253930203,154583.40687304133,0.22521853155162738,-2.1506025539804305,0.21495996255915062,0.36758153597614757,Downregulated
Feature0255,Troxipide,C15 H22 N2 O4,294.1581,NA,NA,Troxipide,15,22,2,4,0,0,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,674141.8284049353,1793372.8738804434,2.660230827278117,1.4115514332908625,0.00906685833482516,0.16912126459608967,Upregulated
Feature0254,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,C14 H16 N2 O5,292.10606,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,14,16,2,5,0,0,0,0,1.1428571428571428,0.35714285714285715,0,60.3,8,3,0.14285714285714285,0.3684210526315789,1,Lignin,71322.40658451493,127046.658938666,1.7813007864242423,0.8329311472330381,0.028061611219612863,0.16912126459608967,Upregulated
Feature0253,NA,C11 H20 N4 O3,256.15361,NA,NA,Feature0253,11,20,4,3,0,0,0,0,1.818181818181818,0.2727272727272727,-0.18181818181818168,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,95727.07956786294,154192.86053814567,1.6107548797499365,0.6877369653819548,0.0343320456670688,0.17252933836885667,Upregulated
Feature0252,MFCD00037215,C8 H14 N2 O5,218.09029,NA,NA,MFCD00037215,8,14,2,5,0,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,670122.066296268,1051147.99429361,1.568591824028798,0.6494699857919373,0.20497795218619735,0.35949979306502305,Upregulated
Feature0251,N-Acetyl-4-aminosalicylic acid,C9 H9 N O4,195.05319,Metabolic pathways;Microbial metabolism in diverse environments;Other,Superpathway of betalain biosynthesis,N-Acetyl-4-aminosalicylic acid,9,9,1,4,0,0,0,0,1,0.4444444444444444,0.22222222222222232,53.96666666666666,6,2,0.25,0.5,1,Lignin,2554895.0326877134,1210228.9550751683,0.4736902845679826,-1.0779840124747682,0.05645509440376111,0.19904785861944638,Downregulated
Feature0250,NA,C12 H19 N O8,305.11118,NA,NA,Feature0250,12,19,1,8,0,0,0,0,1.5833333333333333,0.6666666666666666,0,60.3,4,-4,-1.6666666666666667,-0.14285714285714285,-5,Amino Sugar,1239758.1654949854,1554852.3263550866,1.254157762077975,0.32671883797386597,0.401377276992393,0.5300039719359012,Upregulated
Feature0249,"10,16-Dihydroxyhexadecanoic acid",C16 H32 O4,288.23015,Other,NA,"10,16-Dihydroxyhexadecanoic acid",16,32,0,4,0,0,0,0,2,0.25,-1.5,103.05,1,-3,-0.25,-0.07142857142857142,-3,Lipid,38432.84192946243,52040.62433548313,1.3540665150653102,0.4372986093692688,0.16488079357659832,0.3376600682826145,Upregulated
Feature0248,"1-(3-Methoxyphenyl)-2,3-butanedione",C11 H12 O3,192.07867,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,"1-(3-Methoxyphenyl)-2,3-butanedione",11,12,0,3,0,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,134212.02696673613,201017.89901414595,1.4977636770508456,0.5828100077466315,0.3422740490954165,0.48171903206021577,Upregulated
Feature0247,NA,C28 H41 N O6,487.29353,NA,NA,Feature0247,28,41,1,6,0,0,0,0,1.4642857142857142,0.21428571428571427,-0.9285714285714288,86.76428571428572,9,3,0.09523809523809525,0.20833333333333337,2,Lignin,33059.60310843883,54077.05351954213,1.6357441842893257,0.7099471413635124,0.036958214290896164,0.17252933836885667,Upregulated
Feature0246,"9-Hydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-7H-furo[3,2-g]chromen-7-one",C14 H14 O5,262.08415,NA,NA,"9-Hydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-7H-furo[3,2-g]chromen-7-one",14,14,0,5,0,0,0,0,1,0.35714285714285715,-0.2857142857142856,68.44285714285714,8,3,0.3333333333333333,0.4782608695652174,3,Lignin,25849.67484964007,43545.1543446325,1.6845532718659642,0.7523660525864798,0.01771982510182278,0.16912126459608967,Upregulated
Feature0245,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid,C9 H8 O6 S,244.00421,NA,NA,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid-peak2,9,8,0,6,1,0,0,0,0.8888888888888888,0.6666666666666666,0.6666666666666665,41.3,6,0,-0.5,0.4,-1,Tannin,47408.050330572136,72018.5769439756,1.5191212556052494,0.6032370297337257,0.04905954682514067,0.1831186941809009,Upregulated
Feature0244,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",C14 H23 N O3,253.16783,NA,NA,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",14,23,1,3,0,0,0,0,1.6428571428571428,0.21428571428571427,-1,88.8,4,1,0,0.13043478260869565,0,Lipid,38043.998972148765,50324.634978018934,1.322800871035155,0.40359590062479583,0.18042327248724005,0.34471932508735253,Upregulated
Feature0243,NA,C7 H17 N8 O6 P,340.10075,Other,NA,Feature0243,7,17,8,6,0,1,0,0,2.4285714285714284,0.8571428571428571,2,3.299999999999997,4,-2,1.375,1.6,-11,Carbohydrate,497004.664450068,170259.83112048786,0.3425718978088045,-1.545521287174608,0.3146228100202795,0.45244106620631586,Downregulated
Feature0242,NA,C4 H10 N6 P2,204.04415,NA,NA,Feature0242,4,10,6,0,0,2,0,0,2.5,0,-0.5,74.55,4,4,1,1,-4,Lipid,1389780.8443503527,2335449.7589762164,1.6804446315907549,0.7488430085516626,0.17995185723903429,0.34471932508735253,Upregulated
Feature0241,"(2E)-3-(4,5-Dihydroxy-2,3-dimethoxyphenyl)-2-propen-1-yl hydrogen sulfate",C11 H14 O8 S,306.04103,NA,NA,"(2E)-3-(4,5-Dihydroxy-2,3-dimethoxyphenyl)-2-propen-1-yl hydrogen sulfate",11,14,0,8,1,0,0,0,1.2727272727272727,0.7272727272727273,0.36363636363636376,49.93636363636363,5,-3,-2,0,-4,Tannin,34841.7042438758,53031.8122107009,1.5220785940751567,0.6060428557895449,0.03309860921977475,0.17252933836885667,Upregulated
Feature0240,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10623,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine,8,15,3,4,0,0,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,253242.09655541833,482652.1573767767,1.9058922822934192,0.9304665829453401,0.004257280144743666,0.15566454572065455,Upregulated
Feature0239,Catechin,C15 H14 O6,290.07918,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,NA,Catechin,15,14,0,6,0,0,0,0,0.9333333333333332,0.4,-0.13333333333333375,64.10000000000001,9,3,0.3333333333333333,0.5,3,Lignin,907874.6683980707,1312785.0620187216,1.4459981181489603,0.532065674737904,0.41736647093218804,0.5406792918894254,Upregulated
Feature0238,NA,C30 H50 O6 S,538.3329,NA,NA,Feature0238,30,50,0,6,1,0,0,0,1.6666666666666667,0.2,-1.2000000000000002,94.5,6,0,-0.04347826086956521,0.07692307692307693,-1,Lipid,949706.5428156109,369174.589489409,0.388724909059709,-1.363178537955002,0.5779278100018251,0.6862892743771674,Downregulated
Feature0237,MFCD00155202,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,MFCD00155202-peak2,10,12,0,4,0,0,0,0,1.2,0.4,-0.4000000000000003,71.7,5,1,0.16666666666666666,0.375,1,Lignin,522915.65584272245,2310365.982580777,4.418238308159713,2.143471235969797,0.04129134065827205,0.18042689182236984,Upregulated
Feature0236,pseudouridine,C9 H12 N2 O6,244.06949,Metabolic pathways;ABC transporters;Other,Other,pseudouridine,9,12,2,6,0,0,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,319875.76746752235,312420.855027891,0.9766943507516922,-0.034020942770424424,0.9683791437667207,0.9798392519769779,Downregulated
Feature0235,"(6E,8R,10Z)-8-Hydroxy-3-oxo-6,10-hexadecadienoic acid",C16 H26 O4,282.18315,Other,NA,"(6E,8R,10Z)-8-Hydroxy-3-oxo-6,10-hexadecadienoic acid",16,26,0,4,0,0,0,0,1.625,0.25,-1.125,92.3625,4,0,0,0.14285714285714285,0,Lipid,457260.50541390554,1970919.0856224727,4.310276226105348,2.1077803280760263,0.23597137670986987,0.37535912016174644,Upregulated
Feature0234,"2,4,6-Trihydroxyacetophenone",C8 H8 O4,168.0422,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"2,4,6-Trihydroxyacetophenone-peak2",8,8,0,4,0,0,0,0,1,0.5,0,60.3,5,1,0.25,0.5,1,Lignin,437654.02695870004,2295569.177195018,5.245168639592213,2.390989158234801,0.21181688569382986,0.36586552983479703,Upregulated
Feature0233,NA,C12 H15 N3 O9 P2,407.02843,NA,NA,Feature0233,12,15,3,9,0,2,0,0,1.25,0.75,0.16666666666666652,55.55,8,-1,3,-0.6,-6,Tannin,947473.6505325333,75180.1707189108,0.07934803324256598,-3.655661725584606,0.022384803870366874,0.16912126459608967,Downregulated
Feature0232,cis-trihomoaconitic acid,C9 H12 O6,216.06335,Metabolic pathways;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Other,NA,cis-trihomoaconitic acid-peak1,9,12,0,6,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,4,-2,-0.6666666666666666,0.16666666666666666,-2,Tannin,1705039.33666537,1380037.4012089102,0.8093874267487093,-0.30509765693534463,0.3758712007518885,0.5104421410784786,Downregulated
Feature0231,Pyrogallol,C6 H6 O3,126.03174,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,Pyrogallol,6,6,0,3,0,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,1465727.6175594206,2791470.2830855264,1.9044945661415567,0.929408171644066,0.22744644457318927,0.37535912016174644,Upregulated
Feature0230,NA,C27 H37 N O7,487.25721,NA,NA,Feature0230,27,37,1,7,0,0,0,0,1.3703703703703705,0.25925925925925924,-0.7407407407407405,81.4111111111111,10,3,0.10526315789473684,0.24444444444444444,2,Lignin,43922.83787504563,58864.65169339847,1.340183251839515,0.42243028310419,0.06441310881126416,0.2112639078681919,Upregulated
Feature0229,NA,C10 H20 O9,284.11082,NA,NA,Feature0229,10,20,0,9,0,0,0,0,2,0.9,-0.20000000000000015,66,1,-8,-8,-0.6363636363636364,-8,Carbohydrate,278558.3582768857,532564.6679958337,1.911860305647217,0.934977113427096,0.13325414795743867,0.2998557752594217,Upregulated
Feature0228,5-Aminonicotinic acid,C6 H6 N2 O2,138.04298,Metabolic pathways;Other,NA,5-Aminonicotinic acid,6,6,2,2,0,0,0,0,1,0.3333333333333333,0.6666666666666665,41.3,5,3,0.5,0.6666666666666666,1,Lignin,374988.271873685,1128666.889335874,3.0098725053354896,1.5897023774116124,0.04925999960421896,0.1831186941809009,Upregulated
Feature0227,NA,C27 H37 N O6,471.26226,NA,NA,Feature0227,27,37,1,6,0,0,0,0,1.3703703703703705,0.2222222222222222,-0.8148148148148149,83.52222222222223,10,4,0.15,0.2608695652173913,3,Lignin,34395.279797341165,49419.51780921937,1.4368110421081561,0.5228703425618701,0.09715011417141164,0.26580271237298225,Upregulated
Feature0226,2-[3-carboxylato-3-(methylammonio)propyl]-L-histidine dizwitterion,C11 H18 N4 O4,270.13292,NA,NA,2-[3-carboxylato-3-(methylammonio)propyl]-L-histidine dizwitterion,11,18,4,4,0,0,0,0,1.6363636363636365,0.3636363636363637,0.18181818181818168,55.11818181818182,5,1,-1,-0.2,-3,Protein,702505.6107092707,663901.6911585483,0.9450482402386129,-0.08154012092220661,0.831041555957528,0.875875171257202,Downregulated
Feature0225,UNII:74D1OHC38H,C19 H32 O4,324.23021,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H,19,32,0,4,0,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,52369.510682567,548038.5684440406,10.464840348918406,3.3874783969653977,0.011310731420655503,0.16912126459608967,Upregulated
Feature0224,val-phe,C14 H20 N2 O3,264.14747,Metabolic pathways;Other,NA,val-phe,14,20,2,3,0,0,0,0,1.4285714285714286,0.21428571428571427,-0.5714285714285712,76.58571428571427,6,3,0.1111111111111111,0.23809523809523808,1,Lignin,146872.87216073167,850617.3825309357,5.791521402264502,2.533942386414863,0.08609640193903452,0.2565444413244287,Upregulated
Feature0223,(-)-Shikimic acid,C7 H10 O5,174.05282,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Other,(-)-Shikimic acid-peak1,7,10,0,5,0,0,0,0,1.4285714285714286,0.7142857142857143,0,60.3,3,-2,-1,0.1111111111111111,-2,Tannin,718855.504742701,552367.5170661813,0.7683985354802138,-0.3800733255682617,0.3988051070596156,0.5286486302883276,Downregulated
Feature0222,NP-008177,C28 H41 N O5,471.29858,NA,NA,NP-008177,28,41,1,5,0,0,0,0,1.4642857142857142,0.17857142857142858,-1,88.8,9,4,0.13636363636363635,0.22448979591836735,3,Lignin,60541.1148559737,97756.334585031,1.6147098516040164,0.6912749492791788,0.03252647491726268,0.17252933836885667,Upregulated
Feature0221,D-(-)-Mannitol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Galactose metabolism;Fructose and mannose metabolism;Phosphotransferase system (PTS);Other,Other,D-(-)-Mannitol,6,14,0,6,0,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,3120962.3653022265,2443387.0042523467,0.7828953759318193,-0.35310857244068317,0.22959414198287828,0.37535912016174644,Downregulated
Feature0220,2271703,C10 H17 N O5,231.11056,NA,NA,2271703,10,17,1,5,0,0,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,736431.5955622654,683594.134627188,0.9282520450596148,-0.1074115063596069,0.7620238596730998,0.8554825376281765,Downregulated
Feature0219,2-Hydroxybenzyl alcohol,C7 H8 O2,124.05246,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,2-Hydroxybenzyl alcohol,7,8,0,2,0,0,0,0,1.1428571428571428,0.2857142857142857,-0.5714285714285712,76.58571428571427,4,2,0.4,0.5,2,Lignin,2172694.921619365,139855.08941073233,0.06436940962999756,-3.957480952677616,0.21629280870350556,0.36802059988357666,Downregulated
Feature0218,2'-Deoxyinosine,C10 H12 N4 O4,252.08587,Metabolic pathways;ABC transporters;Other,Other,2'-Deoxyinosine,10,12,4,4,0,0,0,0,1.2,0.4,0.7999999999999998,37.5,7,3,-0.5,0.25,-1,Lignin,346971.023832898,221655.85505665466,0.6388310257383469,-0.6464937138979188,0.02135647178073489,0.16912126459608967,Downregulated
Feature0217,S-inosyl-L-homocysteine,C14 H19 N5 O6 S,385.10554,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,S-inosyl-L-homocysteine,14,19,5,6,1,0,0,0,1.3571428571428572,0.42857142857142855,0.7142857142857144,39.942857142857136,8,2,-2,-0.2,-4,Lignin,105928.33947001646,182751.15057783067,1.7252337900525598,0.7867918777720353,0.020836398782322983,0.16912126459608967,Upregulated
Feature0216,asp-leu,C10 H18 N2 O5,246.12157,Metabolic pathways;Other,NA,asp-leu-peak1,10,18,2,5,0,0,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,320625.4187615573,701184.971598809,2.186928828996762,1.1289062703520893,0.06050495009180817,0.20692692931398393,Upregulated
Feature0215,lys-leu,C12 H25 N3 O3,259.18964,NA,NA,lys-leu,12,25,3,3,0,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,362000.53920173633,312859.669931408,0.864251944544914,-0.21047615036885445,0.7665654853453095,0.8567496600918165,Downregulated
Feature0214,2-Aminooctanedioic acid,C8 H15 N O4,189.10013,NA,NA,2-Aminooctanedioic acid-peak2,8,15,1,4,0,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,2041436.4644626733,1280908.9830994103,0.6274547385615347,-0.6724167008564822,0.18499807882279234,0.34936989719461875,Downregulated
Feature0213,beta-D-Xylopyranosyl-(1->4)-beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranose,C20 H34 O17,546.17964,ABC transporters,NA,beta-D-Xylopyranosyl-(1->4)-beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranose,20,34,0,17,0,0,0,0,1.7,0.85,0,60.3,4,-13,-4.333333333333333,-0.391304347826087,-13,Carbohydrate,285172.566283118,566501.8010375226,1.986522786610204,0.9902453421000598,0.02832468795379506,0.16912126459608967,Upregulated
Feature0212,N-Acetylalanine,C5 H9 N O3,131.05829,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;Other,Other,N-Acetylalanine,5,9,1,3,0,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,1188237.4512182034,1115622.2640973218,0.9388883197996872,-0.09097453450923725,0.7629303332648942,0.8554825376281765,Downregulated
Feature0211,Threonylleucine,C10 H20 N2 O4,232.14232,Other,NA,Threonylleucine,10,20,2,4,0,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,958684.0929377624,1711309.5108315432,1.7850609219846951,0.8359733125430933,0.09146800352740533,0.25931792540325765,Upregulated
Feature0210,2-Hydroxy-3-[4-(sulfooxy)phenyl]propanoic acid,C9 H10 O7 S,262.01468,NA,NA,2-Hydroxy-3-[4-(sulfooxy)phenyl]propanoic acid,9,10,0,7,1,0,0,0,1.1111111111111112,0.7777777777777778,0.6666666666666665,41.3,5,-2,-3,0.1111111111111111,-3,Tannin,873614.7517102023,628359.1400252316,0.7192634268081505,-0.47540784724573226,0.2889341452965011,0.4296325117017538,Downregulated
Feature0209,3-[(2Z)-1-Oxo-2-buten-2-yl]pentanedioic acid,C9 H12 O5,200.06848,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,3-[(2Z)-1-Oxo-2-buten-2-yl]pentanedioic acid-peak2,9,12,0,5,0,0,0,0,1.3333333333333333,0.5555555555555556,-0.22222222222222232,66.63333333333333,4,-1,-0.25,0.2307692307692308,-1,Lignin,105688.5746967076,205064.34848310033,1.9402697885894422,0.9562572687003985,0.02225442129428041,0.16912126459608967,Upregulated
Feature0208,Loganetin,C11 H16 O5,228.09967,NA,NA,Loganetin,11,16,0,5,0,0,0,0,1.4545454545454546,0.4545454545454546,-0.5454545454545459,75.84545454545456,4,-1,-0.16666666666666666,0.17647058823529413,-1,Lignin,89520.7393670593,91138.60144273449,1.0180724833945072,0.025840280186833986,0.9458687969558972,0.9627593111872524,Upregulated
Feature0207,3-Hydroxybutyric acid,C4 H8 O3,104.04737,Metabolic pathways;Microbial metabolism in diverse environments;Carbon metabolism;Other,NA,3-Hydroxybutyric acid-peak2,4,8,0,3,0,0,0,0,2,0.75,-0.5,74.55,1,-2,-2,-0.2,-2,Carbohydrate,621278.9734683867,590664.1919408453,0.9507229717486984,-0.07290307505031049,0.8291901492184469,0.875875171257202,Downregulated
Feature0206,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.09571,Other,NA,N-(2-Cyanoethyl)-L-glutamine,8,13,3,3,0,0,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,3081777.031123675,5140800.067857343,1.6681284907827705,0.7382304194034185,0.3495905923364154,0.4860161893457482,Upregulated
Feature0205,NA,C6 H3 N2 O4 P3,259.93046,NA,NA,Feature0205,6,3,2,4,0,3,0,0,0.5,0.6666666666666666,-0.666666666666667,79.30000000000001,8,4,0.3333333333333333,-1,-1,Condensed HC,716263.831812429,1109388.6659658502,1.5488547888264312,0.63120189218417,0.09092128873464712,0.25931792540325765,Upregulated
Feature0204,Miglitol,C8 H17 N O5,207.11059,NA,NA,Miglitol,8,17,1,5,0,0,0,0,2.125,0.625,-0.5,74.55,1,-4,-2.5,-0.5555555555555556,-5,Amino Sugar,3892617.39977197,4619536.016174504,1.1867428883314133,0.24700740430726978,0.3554607647311231,0.49019186104050044,Upregulated
Feature0203,Cystathionine,C7 H14 N2 O4 S,222.06744,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;Other,Other,Cystathionine,7,14,2,4,1,0,0,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,2288777.1992493835,4564629.31482588,1.9943528432225184,0.9959206756008288,0.027197401356192998,0.16912126459608967,Upregulated
Feature0202,methylguanosine,C11 H15 N5 O5,297.10742,NA,NA,methylguanosine,11,15,5,5,0,0,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,3224465.4580115336,3587960.3085099934,1.1127302665300127,0.1541039158593975,0.673959519298889,0.7734703208061074,Upregulated
Feature0201,melizame,C7 H6 N4 O2,178.04906,NA,NA,melizame,7,6,4,2,0,0,0,0,0.8571428571428571,0.2857142857142857,1.4285714285714284,19.58571428571429,7,5,1,1,1,Lignin,210539.3135431593,351701.29003720067,1.6704779934845944,0.7402609770459648,0.13326923344863187,0.2998557752594217,Upregulated
Feature0200,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11117,NA,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,13085806.052748464,12392191.780069603,0.9469949141930635,-0.07857141712205315,0.932911362509613,0.9552565448451726,Downregulated
Feature0199,"1,5-Anhydro-D-glucitol",C6 H12 O5,164.06849,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Fructose and mannose metabolism;Other,Other,"1,5-Anhydro-D-glucitol",6,12,0,5,0,0,0,0,2,0.8333333333333334,-0.33333333333333304,69.79999999999998,1,-4,-4,-0.42857142857142855,-4,Carbohydrate,334431.190976895,291177.0312354967,0.8706634999712494,-0.19981285106202232,0.4712976737169187,0.5839992913448775,Downregulated
Feature0198,NA,C7 H6 N4 O5 P2,287.98122,NA,NA,Feature0198,7,6,4,5,0,2,0,0,0.8571428571428571,0.7142857142857143,0.8571428571428572,35.87142857142857,8,3,0.75,0.3333333333333333,-3,Tannin,3108793.587167537,5933256.268410893,1.9085397927035619,0.9324692667932444,0.03452200485529393,0.17252933836885667,Upregulated
Feature0197,NA,C18 H28 O15,484.143,NA,NA,Feature0197,18,28,0,15,0,0,0,0,1.5555555555555556,0.8333333333333334,0.11111111111111116,57.133333333333326,5,-10,-3.3333333333333335,-0.23809523809523808,-10,Carbohydrate,69313.90684884714,123333.60156853632,1.7793485777318823,0.8313491649632807,0.0356301628847456,0.17252933836885667,Upregulated
Feature0196,NA,C31 H34 O11,582.21017,NA,NA,Feature0196,31,34,0,11,0,0,0,0,1.096774193548387,0.3548387096774194,-0.387096774193548,71.33225806451611,15,4,0.2,0.37254901960784315,4,Lignin,62777.59801254667,71224.8918903124,1.1345590488517492,0.1821316969509111,0.49987748634577,0.6062343983342318,Upregulated
Feature0195,NA,C11 H23 N O7,281.14757,NA,NA,Feature0195,11,23,1,7,0,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,104995.36165355484,152660.107758107,1.453970016902536,0.5399975189741331,0.11657841080802935,0.2910205583674893,Upregulated
Feature0194,Glu-Gly,C7 H12 N2 O5,204.07461,NA,NA,Glu-Gly,7,12,2,5,0,0,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,1074507.1804884907,1644036.9093037401,1.5300380855122167,0.6135675647452129,0.25523375814437427,0.3967724785698909,Upregulated
Feature0193,NA,C6 H14 O7,198.07397,NA,NA,Feature0193,6,14,0,7,0,0,0,0,2.3333333333333335,1.1666666666666667,0,60.3,0,-7,7,-1.4,-7,Carbohydrate,164681268.57115465,106845949.92106158,0.6488045109689942,-0.6241442446139683,0.23281727485493706,0.37535912016174644,Downregulated
Feature0192,Glycolic acid,C2 H4 O3,76.01606,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Other,Other,Glycolic acid-peak1,2,4,0,3,0,0,0,0,2,1.5,1,31.799999999999997,1,-2,2,-1,-2,Carbohydrate,2998536.8595399,2623945.40456395,0.8750752541913298,-0.1925210045936133,0.730715369933166,0.8247678432909001,Downregulated
Feature0191,L-glycero-ÃÂ±-D-manno-Heptopyranose,C7 H14 O7,210.07387,Metabolic pathways;Other,NA,L-glycero-ÃÂ±-D-manno-Heptopyranose,7,14,0,7,0,0,0,0,2,1,0,60.3,1,-6,-Inf,-0.7142857142857143,-6,Carbohydrate,352056.3030493673,499631.67768770066,1.4191811746021756,0.505058777569951,0.2838750072739168,0.4254098264382675,Upregulated
Feature0190,NP-001596,C16 H30 O4,286.21438,Metabolic pathways;Other,NA,NP-001596,16,30,0,4,0,0,0,0,1.875,0.25,-1.375,99.4875,2,-2,-0.16666666666666666,0,-2,Lipid,41771.86588742454,169332.14187001032,4.053736606508352,2.019252352043795,0.045684188295985924,0.18042689182236984,Upregulated
Feature0189,3-Hydroxybutyric acid,C4 H8 O3,104.04736,Metabolic pathways;Microbial metabolism in diverse environments;Carbon metabolism;Other,NA,3-Hydroxybutyric acid-peak1,4,8,0,3,0,0,0,0,2,0.75,-0.5,74.55,1,-2,-2,-0.2,-2,Carbohydrate,599335.214483771,663692.2830124396,1.1073807561668167,0.1471513563434809,0.28485043934024346,0.4254098264382675,Upregulated
Feature0188,(2S)-5-Carbamimidamido-2-(2-oxo-1-azetidinyl)pentanoic acid,C9 H16 N4 O3,228.12222,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,(2S)-5-Carbamimidamido-2-(2-oxo-1-azetidinyl)pentanoic acid,9,16,4,3,0,0,0,0,1.7777777777777777,0.3333333333333333,0.22222222222222232,53.96666666666666,4,1,-1.5,-0.42857142857142855,-3,Protein,1879613.82951292,2410333.7992298068,1.2823558549015446,0.35879666668523214,0.09147759831478179,0.25931792540325765,Upregulated
Feature0187,2'-O-Methylinosine,C11 H14 N4 O5,282.09642,ABC transporters,NA,2'-O-Methylinosine,11,14,4,5,0,0,0,0,1.2727272727272727,0.4545454545454546,0.7272727272727271,39.57272727272728,7,2,-1,0.1111111111111111,-2,Lignin,111529.29603271741,159126.24866313266,1.4267663683311742,0.5127491141794276,0.19929148025970597,0.35949979306502305,Upregulated
Feature0186,NP-011548,C18 H34 O3,298.25084,Other,NA,NP-011548,18,34,0,3,0,0,0,0,1.8888888888888888,0.16666666666666666,-1.5555555555555554,104.63333333333333,2,-1,-0.06666666666666667,0.0303030303030303,-1,Lipid,240979.01052871565,764215.247321958,3.1712938220023617,1.6650715500712174,0.04622434722990884,0.18042689182236984,Upregulated
Feature0185,4-Dodecylbenzenesulfonic acid,C18 H30 O3 S,326.19169,NA,NA,4-Dodecylbenzenesulfonic acid,18,30,0,3,1,0,0,0,1.6666666666666667,0.16666666666666666,-1.2222222222222223,95.13333333333333,4,1,0,0.0967741935483871,0,Lipid,793888.1144173658,2223373.12519585,2.8006126868741235,1.485742478463363,0.10456343764646553,0.2709169266220028,Upregulated
Feature0184,NA,C7 H18 N O7 P,259.0822,NA,NA,Feature0184,7,18,1,7,0,1,0,0,2.5714285714285716,1,-0.8571428571428568,84.72857142857141,0,-7,4.5,-3.6666666666666665,-9,Other,1179016.2488384454,751082.339647991,0.6370415508589891,-0.6505406199517669,0.2113122376951497,0.36586552983479703,Downregulated
Feature0183,Valylvaline,C10 H20 N2 O3,216.1473,NA,NA,Valylvaline,10,20,2,3,0,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.2307692307692308,-3,Lipid,474796.45328415,1926479.59181621,4.0574852202260985,2.0205858396295997,0.0018036844037247798,0.15434581914546944,Upregulated
Feature0182,NA,C30 H52 O6 S,540.34851,NA,NA,Feature0182,30,52,0,6,1,0,0,0,1.7333333333333334,0.2,-1.2666666666666666,96.4,5,-1,-0.08695652173913043,0.03846153846153846,-2,Lipid,3300897.98563841,919412.0260889811,0.2785339111021216,-1.8440751105875288,0.04866001528780399,0.1831186941809009,Downregulated
Feature0181,"Î±,Î±-Trehalose",C12 H22 O11,342.11625,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,"Î±,Î±-Trehalose-peak3",12,22,0,11,0,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,386012.00235744234,649765.9347467517,1.68327909696724,0.7512744033034964,0.6285749614017236,0.7362076602718818,Upregulated
Feature0180,Adenosine 5'-monophosphate,C10 H14 N5 O7 P,347.06322,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of plant hormones;Other,Superpathway of anaerobic sucrose degradation;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of purine nucleotide salvage;Superpathway of chorismate metabolism;Other,Adenosine 5'-monophosphate,10,14,5,7,0,1,0,0,1.4,0.7,1,31.799999999999997,7,0,2,-5,-6,Tannin,104947.79642411886,244057.95232117802,2.325517644361794,1.2175518860404178,0.1823678651581111,0.3464989438004111,Upregulated
Feature0179,16-Hydroxyhexadecanoic acid,C16 H32 O3,272.23521,Metabolic pathways;Other,NA,16-Hydroxyhexadecanoic acid,16,32,0,3,0,0,0,0,2,0.1875,-1.625,106.6125,1,-2,-0.15384615384615383,-0.03448275862068965,-2,Lipid,364513.40895765164,251723.65388701146,0.69057446914458,-0.5341310968086701,0.4091496491437534,0.5340653755448862,Downregulated
Feature0178,Sorbic acid,C6 H8 O2,112.05247,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Sorbic acid,6,8,0,2,0,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Lignin,331524.88212196267,277021.8149187367,0.8355988640901615,-0.2591175636750228,0.5869482890960861,0.6945893248126693,Downregulated
Feature0177,4-Undecylbenzenesulfonic acid,C17 H28 O3 S,312.17592,NA,NA,4-Undecylbenzenesulfonic acid-peak1,17,28,0,3,1,0,0,0,1.6470588235294117,0.17647058823529413,-1.1764705882352944,93.8294117647059,4,1,0,0.10344827586206896,0,Lipid,844654.845591346,1148085.3312529668,1.3592360681352487,0.4427960409112994,0.3696305253940903,0.507685299938871,Upregulated
Feature0176,4-Carboxy-2-[(5-oxidanidyl-5-oxidanylidenenorvalyl)amino]butanoate,C10 H14 N2 O7,274.08009,NA,NA,4-Carboxy-2-[(5-oxidanidyl-5-oxidanylidenenorvalyl)amino]butanoate,10,14,2,7,0,0,0,0,1.4,0.7,0.6000000000000001,43.2,5,-2,-4,-0.1111111111111111,-4,Tannin,14446094.4736093,12628311.139697334,0.8741678356573975,-0.1940177986572185,0.3440484283810809,0.4822318135505314,Downregulated
Feature0175,Guanine,C5 H5 N5 O,151.04944,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine,5,5,5,1,0,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,200600.30721863848,141008.61610219302,0.7029332011366501,-0.508540496582049,0.635405410421866,0.736639492760265,Downregulated
Feature0174,N-Acetyl-L-methionine,C7 H13 N O3 S,191.0616,NA,NA,N-Acetyl-L-methionine,7,13,1,3,1,0,0,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,167670.81306143635,287872.73808984767,1.716892360892698,0.7797995936358487,0.22066107093243925,0.371754119501942,Upregulated
Feature0173,Pyrrole-2-carboxylic acid,C5 H5 N O2,111.03207,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Pyrrole-2-carboxylic acid,5,5,1,2,0,0,0,0,1,0.4,0.3999999999999999,48.9,4,2,0.5,0.6666666666666666,1,Lignin,1800995.660184111,1258242.978778216,0.6986374296146772,-0.517384157461005,0.4876076615334232,0.5977126173635511,Downregulated
Feature0172,"2,4-Dinitrophenol",C6 H4 N2 O5,184.01199,NA,NA,"2,4-Dinitrophenol",6,4,2,5,0,0,0,0,0.6666666666666666,0.8333333333333334,2,3.299999999999997,6,1,1,1,-1,Condensed HC,416524.2256749483,493920.7031998643,1.185815068498118,0.24587903470372346,0.4308732988951135,0.5475958867974121,Upregulated
Feature0171,NA,C10 H N2 O4 P,243.96742,NA,NA,Feature0171,10,1,2,4,0,1,0,0,0.1,0.4,0.7999999999999998,37.5,12,8,1.6666666666666667,1.4,5,Other,49897.64216321707,93127.48945959276,1.866370542218593,0.9002354418975996,0.01737573938346063,0.16912126459608967,Upregulated
Feature0170,NA,C9 H2 N3 O3 P,230.98339000000001,NA,NA,Feature0170,9,2,3,3,0,1,0,0,0.2222222222222222,0.3333333333333333,0.8888888888888888,34.96666666666667,11,8,2,1.5714285714285714,4,Condensed HC,1733804.878857898,4243848.762130223,2.447708397801808,1.2914316960602192,0.4218326106861645,0.5434187541966283,Upregulated
Feature0169,"(2R)-2,3-Dihydroxypropanoic acid",C3 H6 O4,106.02664,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,"(2R)-2,3-Dihydroxypropanoic acid",3,6,0,4,0,0,0,0,2,1.3333333333333333,0.6666666666666665,41.3,1,-3,3,-1,-3,Carbohydrate,472207.5105354428,1435345.09284637,3.03964901197529,1.603904745406785,0.11841474792554954,0.2925452605851286,Upregulated
Feature0168,2-Aminooctanedioic acid,C8 H15 N O4,189.10017,NA,NA,2-Aminooctanedioic acid-peak1,8,15,1,4,0,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,682765.9733044433,1162986.49646778,1.7033457171850126,0.7683712793202875,0.0198504198731924,0.16912126459608967,Upregulated
Feature0167,beta-D-Ethyl glucuronide,C8 H14 O7,222.07389,NA,NA,beta-D-Ethyl glucuronide-peak4,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,194586.9824339509,173883.035154765,0.8936005532322108,-0.16229801588672554,0.7304788489236287,0.8247678432909001,Downregulated
Feature0166,2-Keto-4-methylthiobutyric acid,C5 H8 O3 S,148.01946,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Other,Other,2-Keto-4-methylthiobutyric acid,5,8,0,3,1,0,0,0,1.6,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,200026.067420955,255586.28255274866,1.2777648725896669,0.3536223837360757,0.25963364450620985,0.39818254000503933,Upregulated
Feature0165,2-Hydroxycinnamic acid,C9 H8 O3,164.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of chorismate metabolism;Other,2-Hydroxycinnamic acid,9,8,0,3,0,0,0,0,0.8888888888888888,0.3333333333333333,-0.22222222222222232,66.63333333333333,6,3,0.5,0.6,3,Lignin,82204.84046155156,140594.141998335,1.7102903090492947,0.7742412326417651,0.059786312897212104,0.20692692931398393,Upregulated
Feature0164,N-Acetylglucosaminitol,C8 H17 N O6,223.10558,NA,NA,N-Acetylglucosaminitol-peak2,8,17,1,6,0,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,4343263.061092733,2259751.016362997,0.520288774724702,-0.9426155135072259,0.1133141848889606,0.2870626017187002,Downregulated
Feature0163,MFCD00025555,C9 H18 N2 O3,202.13173,NA,NA,MFCD00025555,9,18,2,3,0,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,504148.38779136335,4327833.117915697,8.584443038438767,3.1017245347226567,0.197417086526096,0.35949979306502305,Upregulated
Feature0162,NA,C5 H13 O6 P,200.045,NA,NA,Feature0162,5,13,0,6,0,1,0,0,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,7189839.482665255,154297.07801267368,0.021460434323281465,-5.542176915651229,0.2042939376756974,0.35949979306502305,Downregulated
Feature0161,NA,C8 H16 O7,224.08956,NA,NA,Feature0161,8,16,0,7,0,0,0,0,2,0.875,-0.25,67.425,1,-6,-6,-0.5555555555555556,-6,Carbohydrate,1754994.3730913966,1125318.93670398,0.6412094271970498,-0.6411324584303764,0.11915314638996544,0.2925452605851286,Downregulated
Feature0160,ascopyrone P,C6 H8 O4,144.04231,Microbial metabolism in diverse environments;Other,Other,ascopyrone P,6,8,0,4,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,1730430.9575132732,4010454.324919487,2.3176043560170325,1.2126343013184104,0.014321404708363078,0.16912126459608967,Upregulated
Feature0159,NA,C8 H11 N O5,201.06374,NA,NA,Feature0159,8,11,1,5,0,0,0,0,1.375,0.625,0.25,53.175,4,-1,-1,0.1111111111111111,-2,Lignin,16925183.416896533,25070136.4287091,1.4812327766966118,0.5667983789095651,0.13262980265839422,0.2998557752594217,Upregulated
Feature0158,NA,C10 H24 N6 O5 P2,370.12836,NA,NA,Feature0158,10,24,6,5,0,2,0,0,2.4,0.5,-0.5999999999999996,77.39999999999999,3,-2,3.3333333333333335,15,-10,Other,817978.8412003093,1602185.4732229067,1.9587126127515055,0.9699057372822736,0.14528238613271946,0.31722272091709075,Upregulated
Feature0157,3-Hydroxy-3-methylglutaric acid,C6 H10 O5,162.05278,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Fructose and mannose metabolism;Other,Superpathway of butirocin biosynthesis;Other,3-Hydroxy-3-methylglutaric acid,6,10,0,5,0,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,1418712.8643620657,1281474.4324136467,0.9032655335721304,-0.14677793480641302,0.6031915967219816,0.7113500899273024,Downregulated
Feature0156,.alpha.-Glucoheptitol,C7 H16 O7,212.08955,NA,NA,.alpha.-Glucoheptitol-peak2,7,16,0,7,0,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,13879442.9274072,10622428.892200433,0.7653353918999684,-0.3858359782024837,0.30308252339409797,0.4429667649606047,Downregulated
Feature0155,NA,C18 H32 O17,520.16402,NA,NA,Feature0155,18,32,0,17,0,0,0,0,1.7777777777777777,0.9444444444444444,0.11111111111111116,57.133333333333326,3,-14,-14,-0.5789473684210527,-14,Carbohydrate,447391.893616447,502685.46064689633,1.1235909005491571,0.16811684589435422,0.8245967392269027,0.875875171257202,Upregulated
Feature0154,NA,C12 H23 N O14,405.11204,NA,NA,Feature0154,12,23,1,14,0,0,0,0,1.9166666666666667,1.1666666666666667,0.6666666666666665,41.3,2,-12,4.333333333333333,-1.5,-13,Carbohydrate,687134.7500224647,461357.7027806223,0.6714224579175176,-0.5747073013961878,0.21330379268137617,0.3665823974725158,Downregulated
Feature0153,beta-D-Ethyl glucuronide,C8 H14 O7,222.07391,NA,NA,beta-D-Ethyl glucuronide-peak3,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,7717256.181560907,932554.3817536694,0.12084014833949042,-3.048828234701623,0.15637917704592327,0.3285065683008145,Downregulated
Feature0152,4-Acetamidobutanoic acid,C6 H11 N O3,145.07394,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid,6,11,1,3,0,0,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,829615.2111037264,335166.74599387235,0.4040026526851695,-1.3075633291301563,0.39270768870318495,0.5225915546166897,Downregulated
Feature0151,3-Phenyllactic acid,C9 H10 O3,166.06292,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,3-Phenyllactic acid,9,10,0,3,0,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Lignin,10455148.631816324,1070658.079138194,0.10240486451622961,-3.287643845889776,0.12478563702346279,0.2965243003787072,Downregulated
Feature0150,Mevalonic acid,C6 H12 O4,148.07362,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Biosynthesis of terpenoids and steroids;Other,Superpathway of branched chain amino acid biosynthesis;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of L-threonine metabolism;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of L-isoleucine biosynthesis I;Other,Mevalonic acid-peak1,6,12,0,4,0,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,3104069.9044420435,1627182.9039699167,0.5242094907854219,-0.9317846210662966,0.028501629717498873,0.16912126459608967,Downregulated
Feature0149,N-Acetylvaline,C7 H13 N O3,159.08948,Metabolic pathways;Other,Superpathway of L-lysine degradation,N-Acetylvaline,7,13,1,3,0,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,1047241.656578456,583310.1902308234,0.5569967414556561,-0.8442592073570939,0.1456256350408867,0.31722272091709075,Downregulated
Feature0148,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one",C8 H10 O5,186.05291,NA,NA,"6-(1-Hydroxyethyl)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]hept-3-en-5-one-peak1",8,10,0,5,0,0,0,0,1.25,0.625,0,60.3,4,-1,-0.3333333333333333,0.2727272727272727,-1,Lignin,666113.787021235,608611.937036276,0.9136756345457148,-0.1302460121950428,0.8068930343351037,0.875875171257202,Downregulated
Feature0147,Acrylic acid,C3 H4 O2,72.02116,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-threonine metabolism;Other,Acrylic acid-peak2,3,4,0,2,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,2,0,0,0.5,0,Tannin,421779.50367161236,692193.832286477,1.6411272389030143,0.7146870973635706,0.13096520092785752,0.2998557752594217,Upregulated
Feature0146,"5,7-Dihydroxy-2,2-dimethyl-3,4-dihydro-2H-chromen-4-yl hydrogen sulfate",C11 H14 O7 S,290.04605,NA,NA,"5,7-Dihydroxy-2,2-dimethyl-3,4-dihydro-2H-chromen-4-yl hydrogen sulfate",11,14,0,7,1,0,0,0,1.2727272727272727,0.6363636363636364,0.18181818181818168,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Lignin,30418.353073792397,46268.855366498334,1.5210835134385459,0.6050993648415313,0.07885906182499516,0.2397261064057066,Upregulated
Feature0145,DL-4-Hydroxyphenyllactic acid,C9 H10 O4,182.05791,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,DL-4-Hydroxyphenyllactic acid,9,10,0,4,0,0,0,0,1.1111111111111112,0.4444444444444444,-0.22222222222222232,66.63333333333333,5,1,0.2,0.42857142857142855,1,Lignin,10908312.74589413,777513.9626966467,0.07127719756561816,-3.8104155748237747,0.07920774860773347,0.2397261064057066,Downregulated
Feature0144,NA,C5 H12 N2 S2,164.04417,NA,NA,Feature0144,5,12,2,0,2,0,0,0,2.4,0,-0.4000000000000003,71.7,1,1,-3,-3,-3,Lipid,48184.962709746665,76313.760412995,1.5837671364962695,0.6633602295346308,0.045327938239090856,0.18042689182236984,Upregulated
Feature0143,NA,C33 H38 O10,594.2465,NA,NA,Feature0143,33,38,0,10,0,0,0,0,1.1515151515151516,0.30303030303030304,-0.5454545454545459,75.84545454545456,15,5,0.21739130434782608,0.35714285714285715,5,Lignin,28327.6886569077,51751.24348475617,1.826878433731184,0.8693806356685749,0.024835206419477236,0.16912126459608967,Upregulated
Feature0142,"2-(3,4-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",C21 H24 O8,404.14731,NA,NA,"2-(3,4-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",21,24,0,8,0,0,0,0,1.1428571428571428,0.380952380952381,-0.3809523809523814,71.15714285714287,10,2,0.15384615384615383,0.35294117647058826,2,Lignin,120368.32155544733,153077.62570668367,1.2717434598119646,0.3468076748798363,0.19831218177877952,0.35949979306502305,Upregulated
Feature0141,.,C3 H6 O2,74.0368,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Fructose and mannose metabolism;Other,Superpathway of L-threonine metabolism;Superpathway of coenzyme A biosynthesis II (plants);Other,.,3,6,0,2,0,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-1,-1,0,-1,Amino Sugar,907316.3507901009,117499.19790487648,0.12950190724828986,-2.94895474942814,0.1984526429080686,0.35949979306502305,Downregulated
Feature0140,D-(-)-Glutamine,C5 H10 N2 O3,146.06919,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;Central carbon metabolism in cancer;Other,Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Superpathway of purine nucleotide salvage;Superpathway of chorismate metabolism;Superpathway of butirocin biosynthesis;Other,D-(-)-Glutamine,5,10,2,3,0,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,7421470.70624316,21447834.4354168,2.8899709079730314,1.5310549698421176,0.001965473228445096,0.15434581914546944,Upregulated
Feature0139,"3,12-Dihydroxy-13-methoxypodocarpa-8,11,13-trien-7-one",C18 H24 O4,304.16748,NA,NA,"3,12-Dihydroxy-13-methoxypodocarpa-8,11,13-trien-7-one",18,24,0,4,0,0,0,0,1.3333333333333333,0.2222222222222222,-0.8888888888888893,85.63333333333334,7,3,0.21428571428571427,0.3125,3,Lignin,685961.5818137624,35286688.02407973,51.44120160603982,5.684852437608194,0.05062342971312735,0.18616358023537155,Upregulated
Feature0138,cis-Aconitic acid,C6 H6 O6,174.0164,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Other,Superpathway of betalain biosynthesis;Other,cis-Aconitic acid,6,6,0,6,0,0,0,0,1,1,1,31.799999999999997,4,-2,-Inf,0.3333333333333333,-2,Tannin,4058037.501703771,7744307.295803553,1.9083873159260107,0.9323540026109951,0.20324263342376367,0.35949979306502305,Upregulated
Feature0137,glutaral,C5 H8 O2,100.05245,NA,NA,glutaral,5,8,0,2,0,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,132005.77796849282,123243.028552075,0.9336184404101666,-0.09909503809920966,0.8743119852326849,0.9033995702302927,Downregulated
Feature0136,beta-D-Ethyl glucuronide,C8 H14 O7,222.07396,NA,NA,beta-D-Ethyl glucuronide-peak2,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,1154599.5529366897,667749.688224761,0.5783387725435711,-0.7900132694713912,0.11975536983016959,0.2925452605851286,Downregulated
Feature0135,MS 3 (enzyme inhibitor),C21 H24 O7,388.15231,NA,NA,MS 3 (enzyme inhibitor),21,24,0,7,0,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,35941.45814856143,135333.25539920438,3.7653802146761577,1.9127955504569214,0.23454136328215394,0.37535912016174644,Upregulated
Feature0134,UDP-N-acetylglucosamine,C17 H27 N3 O17 P2,607.08161,Metabolic pathways;Other,Chitin biosynthesis;Superpathway of CMP-sialic acids biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Superpathway of butirocin biosynthesis;Other,UDP-N-acetylglucosamine,17,27,3,17,0,2,0,0,1.588235294117647,1,0.3529411764705883,50.24117647058823,7,-10,3,-1.8571428571428572,-15,Carbohydrate,12118111.759463767,16996359.2146704,1.4025583813746325,0.48806082414364205,0.005074094968867742,0.15566454572065455,Upregulated
Feature0133,NA,C4 H11 O6 P,186.02928,NA,NA,Feature0133,4,11,0,6,0,1,0,0,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,11551191.086402979,17471491.715837233,1.5125272870261057,0.5969611698266627,0.2351542424553235,0.37535912016174644,Upregulated
Feature0132,(Â±)9-HpODE,C18 H32 O4,312.2302,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,(Â±)9-HpODE,18,32,0,4,0,0,0,0,1.7777777777777777,0.2222222222222222,-1.333333333333333,98.29999999999998,3,-1,-0.07142857142857142,0.0625,-1,Lipid,3619486.4687948264,15580941.924551968,4.3047382712664,2.105925524213362,0.0013870884369046519,0.15434581914546944,Upregulated
Feature0131,"3,5-Dihydroxybenzoic acid",C7 H6 O4,154.02666,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of phenylpropanoids;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Other,"3,5-Dihydroxybenzoic acid",7,6,0,4,0,0,0,0,0.8571428571428571,0.5714285714285714,0.2857142857142856,52.15714285714286,5,1,0.3333333333333333,0.6,1,Lignin,140277.31239923366,151841.29647987167,1.082436595646533,0.11428252072538425,0.800965399150783,0.875875171257202,Upregulated
Feature0130,Adenosine,C10 H13 N5 O4,267.09685,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Adenosine-peak2,10,13,5,4,0,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,132616214.358838,173339235.85709932,1.3070742268971078,0.38634107207110224,0.04642563298353376,0.18042689182236984,Upregulated
Feature0129,1-Deoxy-L-mannitol,C6 H14 O5,166.08408,NA,NA,1-Deoxy-L-mannitol-peak2,6,14,0,5,0,0,0,0,2.3333333333333335,0.8333333333333334,-0.666666666666667,79.30000000000001,0,-5,-5,-0.7142857142857143,-5,Carbohydrate,164004916.91618267,158924033.06696534,0.9690199297389724,-0.04540175717280119,0.8208454926108948,0.875875171257202,Downregulated
Feature0128,Methyl acetoacetate,C5 H8 O3,116.04739,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of L-lysine degradation;Other,Methyl acetoacetate,5,8,0,3,0,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,50399112.92680383,719458.4942934227,0.014275221378168189,-6.130343070897014,0.20313454162366795,0.35949979306502305,Downregulated
Feature0127,4-Hydroxy-2-methylbenzoic acid,C8 H8 O3,152.04741,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of phenylpropanoids;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,4-Hydroxy-2-methylbenzoic acid,8,8,0,3,0,0,0,0,1,0.375,-0.25,67.425,5,2,0.4,0.5384615384615384,2,Lignin,46450109.12648568,368152.07536342967,0.007925752647016079,-6.9792363413899645,0.17975074042901182,0.34471932508735253,Downregulated
Feature0126,4-Nitrophenol,C6 H5 N O3,139.02701,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,4-Nitrophenol,6,5,1,3,0,0,0,0,0.8333333333333334,0.5,0.6666666666666665,41.3,5,2,0.5,0.7142857142857143,1,Lignin,1549221.49997481,1948809.9316629532,1.2579285348768012,0.3310499625133124,0.17237084140397732,0.34471932508735253,Upregulated
Feature0125,D-(â)-Erythrose,C4 H8 O4,120.04229,NA,NA,D-(â)-Erythrose-peak2,4,8,0,4,0,0,0,0,2,1,0,60.3,1,-3,-Inf,-0.5,-3,Carbohydrate,1746916.3648911468,3935595.5603810735,2.2528814999259033,1.1717714307658207,0.062154554265170255,0.2104639362246359,Upregulated
Feature0124,Acrylic acid,C3 H4 O2,72.02115,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-threonine metabolism;Other,Acrylic acid-peak1,3,4,0,2,0,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,2,0,0,0.5,0,Tannin,5315265.168808233,12487301.980069833,2.3493281301090168,1.2322482283012606,0.0063722328657577895,0.15566454572065455,Upregulated
Feature0123,"1,5-Anhydro-D-fructose",C6 H10 O5,162.0528,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Fructose and mannose metabolism;Other,Superpathway of butirocin biosynthesis;Other,"1,5-Anhydro-D-fructose",6,10,0,5,0,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,4749707.367609844,11761049.280616457,2.4761629233876095,1.3081062422704575,0.01374240975572592,0.16912126459608967,Upregulated
Feature0122,NA,C7 H8 O6 S,220.00407,NA,NA,Feature0122,7,8,0,6,1,0,0,0,1.1428571428571428,0.8571428571428571,0.8571428571428572,35.87142857142857,4,-2,-Inf,0,-3,Tannin,29141.8383321351,52049.68363322923,1.7860809959896504,0.8367975059143546,0.026677703014317218,0.16912126459608967,Upregulated
Feature0121,Xylitol,C5 H12 O5,152.0685,Metabolic pathways;ABC transporters;Other,Other,Xylitol,5,12,0,5,0,0,0,0,2.4,1,-0.4000000000000003,71.7,0,-5,-Inf,-1,-5,Carbohydrate,364365393.9926223,246163678.20629135,0.6755956582728482,-0.5657680382228386,0.24176902417066207,0.38222674393948863,Downregulated
Feature0120,Gluconic acid,C6 H12 O7,196.05834,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Galactose metabolism;Carbon metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,Gluconic acid,6,12,0,7,0,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,622700.0861590856,729529.7659871234,1.1715588004603956,0.22842936478896533,0.620053110282038,0.7287222120840448,Upregulated
Feature0119,NA,C27 H37 N O5,455.26725,NA,NA,Feature0119,27,37,1,5,0,0,0,0,1.3703703703703705,0.18518518518518515,-0.8888888888888893,85.63333333333334,10,5,0.1904761904761905,0.2765957446808511,4,Lignin,1876579.6503804857,789258.2168264106,0.42058338246734406,-1.249536245544164,0.31178062306151155,0.45244106620631586,Downregulated
Feature0118,Glyceraldehyde,C3 H6 O3,90.03168,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Galactose metabolism;Carbon metabolism;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Other,Superpathway of anaerobic sucrose degradation;Superpathway of microbial D-galacturonate and D-glucuronate degradation;Homolactic fermentation;Superpathway of coenzyme A biosynthesis II (plants);Other,Glyceraldehyde,3,6,0,3,0,0,0,0,2,1,0,60.3,1,-2,-Inf,-0.3333333333333333,-2,Carbohydrate,57527753.062756665,147884441.59256032,2.5706625710069733,1.3621402523018653,0.01986249301760857,0.16912126459608967,Upregulated
Feature0117,D-(+)-Glucose,C6 H12 O6,180.06335,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Galactose metabolism;Carbon metabolism;Biosynthesis of phenylpropanoids;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of scopolin and esculin biosynthesis;Homolactic fermentation;Superpathway of CMP-sialic acids biosynthesis;Superpathway of betalain biosynthesis;Other,D-(+)-Glucose,6,12,0,6,0,0,0,0,2,1,0,60.3,1,-5,-Inf,-0.6666666666666666,-5,Carbohydrate,103951329.44207656,266289178.82701433,2.5616717001719076,1.3570855939922548,0.01188946944531655,0.16912126459608967,Upregulated
Feature0116,L-Iditol,C6 H14 O6,182.07904,Metabolic pathways;ABC transporters;Galactose metabolism;Fructose and mannose metabolism;Phosphotransferase system (PTS);Other,Other,L-Iditol-peak3,6,14,0,6,0,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,1354128550.84196,1604015120.69156,1.1845368149827633,0.24432303772351452,0.339808053704426,0.4802246048219574,Upregulated
Feature0115,D-(+)-Maltose,C12 H22 O11,342.11635,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,D-(+)-Maltose,12,22,0,11,0,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,5351287.83875371,5349203.337039243,0.999610467278667,-5.620864079639562e-4,0.9983440877807055,0.9983440877807055,Downregulated
Feature0114,NA,C29 H30 O10,538.1839,NA,NA,Feature0114,29,30,0,10,0,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,61231.021577326464,227814.125326693,3.720567115461151,1.8955225439957333,0.23590394989294636,0.37535912016174644,Upregulated
Feature0113,NA,C29 H30 O10,538.18389,NA,NA,Feature0113,29,30,0,10,0,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,81652.65910271344,123550.699886579,1.5131252459416011,0.5975314087181891,0.06486172609988348,0.2112639078681919,Upregulated
Feature0112,MFCD12974029,C4 H11 N O4 S,169.04083,NA,NA,MFCD12974029,4,11,1,4,1,0,0,0,2.75,1,0.5,46.05,0,-4,3,-Inf,-6,Other,79072757.2049696,128488785.509404,1.6249437865982077,0.7003898103264772,0.1213539047030146,0.29434776885412056,Upregulated
Feature0111,Perillic acid,C10 H14 O2,166.09931,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Perillic acid,10,14,0,2,0,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Lignin,42492.5161230668,67298.25057587704,1.5837671363344992,0.6633602293872699,0.045327938255211225,0.18042689182236984,Upregulated
Feature0110,NA,C12 H23 N O14,405.11202,NA,NA,Feature0110,12,23,1,14,0,0,0,0,1.9166666666666667,1.1666666666666667,0.6666666666666665,41.3,2,-12,4.333333333333333,-1.5,-13,Carbohydrate,388327.21924134565,476773.146312252,1.2277613380893013,0.2960301455466044,0.37611526184730004,0.5104421410784786,Upregulated
Feature0109,MFCD00155202,C10 H12 O4,196.07357,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,MFCD00155202-peak1,10,12,0,4,0,0,0,0,1.2,0.4,-0.4000000000000003,71.7,5,1,0.16666666666666666,0.375,1,Lignin,945122.091432741,413074.2301241423,0.43705912058192375,-1.194099649941019,0.007951770238929692,0.1599709071596444,Downregulated
Feature0108,3-Allyl-2-hydroxybenzoic acid,C10 H10 O3,178.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,NA,3-Allyl-2-hydroxybenzoic acid-peak2,10,10,0,3,0,0,0,0,1,0.3,-0.4000000000000003,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Lignin,436201.1028901327,209083.67554858234,0.4793286265515126,-1.0609129914616033,0.22376104685492154,0.3751288138450155,Downregulated
Feature0107,beta-D-Ethyl glucuronide,C8 H14 O7,222.0739,NA,NA,beta-D-Ethyl glucuronide-peak1,8,14,0,7,0,0,0,0,1.75,0.875,0,60.3,2,-5,-5,-0.3333333333333333,-5,Carbohydrate,393964.14872998704,553113.8272870054,1.4039699527737877,0.48951205996717817,0.2300148886853314,0.37535912016174644,Upregulated
Feature0106,DL-Lactic Acid,C3 H6 O3,90.03169,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Galactose metabolism;Carbon metabolism;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Other,Superpathway of anaerobic sucrose degradation;Superpathway of microbial D-galacturonate and D-glucuronate degradation;Homolactic fermentation;Superpathway of coenzyme A biosynthesis II (plants);Other,DL-Lactic Acid,3,6,0,3,0,0,0,0,2,1,0,60.3,1,-2,-Inf,-0.3333333333333333,-2,Carbohydrate,4078755.38832081,6346715.17068455,1.5560421173718486,0.637881110260586,0.5101019086390137,0.6140978159947938,Upregulated
Feature0105,Gentisyl Alcohol,C7 H8 O3,140.04739,Microbial metabolism in diverse environments;Other,NA,Gentisyl Alcohol,7,8,0,3,0,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,9014728.635433717,7057094.119017636,0.7828404386216009,-0.3532098127448363,0.2664371755759329,0.404984506875418,Downregulated
Feature0104,NA,C10 H5 N2 O6 P,279.98865,NA,NA,Feature0104,10,5,2,6,0,1,0,0,0.5,0.6,0.7999999999999998,37.5,10,4,1,1,1,Condensed HC,26954514.502974533,86427896.42600434,3.2064349152520144,1.6809701234095682,0.006097959373802433,0.15566454572065455,Upregulated
Feature0103,NA,C28 H28 O10,524.16829,NA,NA,Feature0103,28,28,0,10,0,0,0,0,1,0.35714285714285715,-0.2857142857142856,68.44285714285714,15,5,0.2777777777777778,0.43478260869565216,5,Lignin,75184.95865931224,114649.3735355705,1.5248977399200883,0.608712498376006,0.06356387414481937,0.21105674716046818,Upregulated
Feature0102,NA,C10 H3 N2 O5 P,261.97802,NA,NA,Feature0102,10,3,2,5,0,1,0,0,0.3,0.5,0.7999999999999998,37.5,11,6,1.5,1.2222222222222223,3,Condensed HC,35063863.42357633,12871909.22274258,0.36709900067907897,-1.4457589077648008,0.020790259839890912,0.16912126459608967,Downregulated
Feature0101,Phenylacetaldehyde,C8 H8 O,120.05755,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,Phenylacetaldehyde,8,8,0,1,0,0,0,0,1,0.125,-0.75,81.675,5,4,0.5714285714285714,0.6,4,Unsaturated HC,48389.685097277565,76637.99300042367,1.58376713645395,0.6633602294960809,0.04532793825217028,0.18042689182236984,Upregulated
Feature0100,Î´-Gluconic acid Î´-lactone,C6 H10 O6,178.04765,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Galactose metabolism;Carbon metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,Î´-Gluconic acid Î´-lactone,6,10,0,6,0,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,449314.520600077,625545.33090522,1.3922214890134863,0.47738874831456235,0.1116591957725202,0.2849809324940441,Upregulated
Feature0099,NA,C18 H34 O18,538.17464,NA,NA,Feature0099,18,34,0,18,0,0,0,0,1.8888888888888888,1,0.11111111111111116,57.133333333333326,2,-16,-Inf,-0.7777777777777778,-16,Carbohydrate,187558.493451539,247775.70972841367,1.3210583278247194,0.4016941663619908,0.2986610184540077,0.43837797558485253,Upregulated
Feature0098,"8-(3-Furyl)-10-methyl-6,15-dioxo-7,14-dioxatetracyclo[11.2.1.0~2,11~.0~5,10~]hexadec-3-yl acetate",C21 H24 O7,388.15237,NA,NA,"8-(3-Furyl)-10-methyl-6,15-dioxo-7,14-dioxatetracyclo[11.2.1.0~2,11~.0~5,10~]hexadec-3-yl acetate",21,24,0,7,0,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,40048.1382624568,57523.90311745373,1.4363689702744464,0.5224263920648642,0.10143992250837146,0.26686502690663877,Upregulated
Feature0097,NA,C32 H36 O11,596.22573,NA,NA,Feature0097,32,36,0,11,0,0,0,0,1.125,0.34375,-0.4375,72.76875,15,4,0.1904761904761905,0.3584905660377358,4,Lignin,41360.85302263937,61276.48313348427,1.4815091724521212,0.5670675584694438,0.12485233700156093,0.2965243003787072,Upregulated
Feature0096,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09473,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak2",14,16,0,6,0,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,87289.6433887434,92677.0580266435,1.0617188297345577,0.08640175422571521,0.8255180077743636,0.875875171257202,Upregulated
Feature0095,1-Deoxy-L-mannitol,C6 H14 O5,166.08409,NA,NA,1-Deoxy-L-mannitol-peak1,6,14,0,5,0,0,0,0,2.3333333333333335,0.8333333333333334,-0.666666666666667,79.30000000000001,0,-5,-5,-0.7142857142857143,-5,Carbohydrate,44609103.47425053,38987691.989094,0.8739851051164623,-0.1943194020696403,0.4832887620365955,0.5945494842320707,Downregulated
Feature0094,NA,C9 H17 N O6,235.10561,NA,NA,Feature0094,9,17,1,6,0,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,24135586.959828593,22874029.612915166,0.9477304053548327,-0.07745137138872113,0.9327840328093702,0.9552565448451726,Downregulated
Feature0093,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid,C9 H8 O6 S,244.00412,NA,NA,(2E)-3-[4-(Sulfooxy)phenyl]acrylic acid-peak1,9,8,0,6,1,0,0,0,0.8888888888888888,0.6666666666666666,0.6666666666666665,41.3,6,0,-0.5,0.4,-1,Tannin,48021.882998412904,178668.6387229684,3.7205671158057942,1.895522544129373,0.2359039499258594,0.37535912016174644,Upregulated
Feature0092,L-Saccharopine,C11 H20 N2 O6,276.13221,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Superpathway of L-lysine degradation,L-Saccharopine,11,20,2,6,0,0,0,0,1.818181818181818,0.5454545454545454,-0.18181818181818168,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,36438925.850509234,14720169.0799506,0.40396824923819447,-1.3076861892040827,0.05568963953479437,0.1989261788103176,Downregulated
Feature0091,L-Iditol,C6 H14 O6,182.07903,Metabolic pathways;ABC transporters;Galactose metabolism;Fructose and mannose metabolism;Phosphotransferase system (PTS);Other,Other,L-Iditol-peak2,6,14,0,6,0,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,44191410.26002017,13490406.351993868,0.30527213937317127,-1.7118321667323655,0.04423443040805372,0.18042689182236984,Downregulated
Feature0090,EPERVUDINE,C12 H18 N2 O5,270.12157,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,EPERVUDINE,12,18,2,5,0,0,0,0,1.5,0.4166666666666667,-0.16666666666666696,65.05000000000001,5,0,-0.4,0.06666666666666667,-2,Protein,82307.69176840094,149138.65352066734,1.8119649611887638,0.8575550575872587,0.02638711994202238,0.16912126459608967,Upregulated
Feature0089,"2,4,6-Trihydroxyacetophenone",C8 H8 O4,168.04223,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"2,4,6-Trihydroxyacetophenone-peak1",8,8,0,4,0,0,0,0,1,0.5,0,60.3,5,1,0.25,0.5,1,Lignin,147522.4390335532,305870.02308350167,2.0733796504946147,1.0519843083127864,0.21981701414114352,0.371754119501942,Upregulated
Feature0088,N-Acetyl-b-D-galactosamine,C8 H15 N O6,221.08996,Metabolic pathways;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of CMP-sialic acids biosynthesis;Other,N-Acetyl-b-D-galactosamine,8,15,1,6,0,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,17716113.753050264,22339422.031112466,1.2609662786380669,0.3345296949427917,0.7046871946769984,0.8060301691623192,Upregulated
Feature0087,NA,C15 H31 O17 P,514.12992,NA,NA,Feature0087,15,31,0,17,0,1,0,0,2.066666666666667,1.1333333333333333,-0.13333333333333375,64.10000000000001,1,-16,5.666666666666667,-1.5454545454545454,-17,Carbohydrate,2569491.432241713,3245140.6021875534,1.2629505440134434,0.3367981456151503,0.4924258520184842,0.5993456072573017,Upregulated
Feature0086,3-Allyl-2-hydroxybenzoic acid,C10 H10 O3,178.06298,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,NA,3-Allyl-2-hydroxybenzoic acid-peak1,10,10,0,3,0,0,0,0,1,0.3,-0.4000000000000003,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Lignin,41228.0548181931,63213.092973528735,1.5332543155937128,0.6165970116842202,0.19840383093045824,0.35949979306502305,Upregulated
Feature0085,NA,C6 H13 N O9,243.05903,NA,NA,Feature0085,6,13,1,9,0,0,0,0,2.1666666666666665,1.5,1.3333333333333337,22.29999999999999,1,-8,2.25,-9,-9,Carbohydrate,4680072.452554306,10761597.100600123,2.299450961432578,1.2012894308326907,0.004195542176793343,0.15566454572065455,Upregulated
Feature0084,6-Deoxy-3-O-methyl-beta-D-galactopyranose,C7 H14 O5,178.08412,NA,NA,6-Deoxy-3-O-methyl-beta-D-galactopyranose-peak1,7,14,0,5,0,0,0,0,2,0.7142857142857143,-0.5714285714285712,76.58571428571427,1,-4,-2,-0.3333333333333333,-4,Carbohydrate,1648784.2555041332,533068.0454733013,0.3233097621436894,-1.629011025457199,0.016900919542775096,0.16912126459608967,Downregulated
Feature0083,D-Raffinose,C18 H32 O16,504.16918,Metabolic pathways;ABC transporters;Galactose metabolism;Other,NA,D-Raffinose,18,32,0,16,0,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,2181766.1657380713,1521131.4352390757,0.697201862934056,-0.5203516705153689,0.7810916450969828,0.8701364416993381,Downregulated
Feature0082,"7a-Hydroxy-3,6-dimethyl-5,6,7,7a-tetrahydro-1-benzofuran-2(4H)-one",C10 H14 O3,182.09428,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"7a-Hydroxy-3,6-dimethyl-5,6,7,7a-tetrahydro-1-benzofuran-2(4H)-one",10,14,0,3,0,0,0,0,1.4,0.3,-0.7999999999999998,83.1,4,1,0.14285714285714285,0.29411764705882354,1,Lignin,936487.1196518124,1618303.2132629268,1.72805709689271,0.7891508865078019,0.29102394268050974,0.4308666164360794,Upregulated
Feature0081,9(S)-HpOTrE,C18 H30 O4,310.2145,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,9(S)-HpOTrE,18,30,0,4,0,0,0,0,1.6666666666666667,0.2222222222222222,-1.2222222222222223,95.13333333333333,4,0,0,0.125,0,Lipid,1504917.2720367927,24209896.7702027,16.08719443922417,4.007840840989748,0.028681384054307608,0.16912126459608967,Upregulated
Feature0080,"4-(1,3-Benzodioxol-5-ylmethyl)-3-(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",C22 H26 O7,402.16802,NA,NA,"4-(1,3-Benzodioxol-5-ylmethyl)-3-(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",22,26,0,7,0,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,48649.831453995,77050.00424918864,1.5837671364195751,0.6633602294647678,0.04532793824059952,0.18042689182236984,Upregulated
Feature0079,Glycerol 3-phosphate,C3 H9 O6 P,172.01364,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Other,Glycerol 3-phosphate,3,9,0,6,0,1,0,0,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,25171584.616925232,53662535.31341496,2.1318695715855953,1.0921191762853462,0.12787888293099148,0.29955190385204855,Upregulated
Feature0078,Glucose 1-phosphate,C6 H13 O9 P,260.02973,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Galactose metabolism;Carbon metabolism;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Fructose and mannose metabolism;Glucagon signaling pathway;Central carbon metabolism in cancer;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Homolactic fermentation;Superpathway of CMP-sialic acids biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of butirocin biosynthesis;Other,Glucose 1-phosphate,6,13,0,9,0,1,0,0,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,1328290.61417648,2641406.9519570433,1.9885760870144182,0.9917357636811331,0.13111405740248624,0.2998557752594217,Upregulated
Feature0077,NA,C6 H7 N3 O6 P2,278.98094,NA,NA,Feature0077,6,7,3,6,0,2,0,0,1.1666666666666667,1,0.6666666666666665,41.3,6,0,1,1,-5,Tannin,274457.89539826603,497433.11302985536,1.8124204891538276,0.8579177055167619,0.02705464194965178,0.16912126459608967,Upregulated
Feature0076,Azelaic acid,C9 H16 O4,188.10484,NA,NA,Azelaic acid,9,16,0,4,0,0,0,0,1.7777777777777777,0.4444444444444444,-0.8888888888888893,85.63333333333334,2,-2,-0.4,0,-2,Protein,3469113.38462077,3811930.647660143,1.0988198496362633,0.13595487733305275,0.5117481799956616,0.6140978159947938,Upregulated
Feature0075,L-Glutathione oxidized,C20 H32 N6 O12 S2,612.15171,Metabolic pathways;Biosynthesis of cofactors;Other,Other,L-Glutathione oxidized,20,32,6,12,2,0,0,0,1.6,0.6,0.7000000000000002,40.349999999999994,8,-4,-Inf,-1,-12,Amino Sugar,79305.62344759813,140735.42503424032,1.7745957842098354,0.8274904462924105,0.10771198904736809,0.2769736861218037,Upregulated
Feature0074,NA,C18 H22 O7 S,382.10881,NA,NA,Feature0074,18,22,0,7,1,0,0,0,1.2222222222222223,0.3888888888888889,-0.33333333333333304,69.79999999999998,8,1,0,0.25925925925925924,0,Lignin,50359.150236348265,7346639.36332385,145.8848953734169,7.188686707040507,0.09945242757099439,0.26686502690663877,Upregulated
Feature0073,N-Phenylacetylglutamic acid,C13 H15 N O5,265.0951,NA,NA,N-Phenylacetylglutamic acid,13,15,1,5,0,0,0,0,1.1538461538461535,0.38461538461538464,-0.1538461538461542,64.6846153846154,7,2,0.14285714285714285,0.3684210526315789,1,Lignin,1234769.84233339,452814.10466689797,0.36671943964164083,-1.4472513501597377,0.007075940527214686,0.1599709071596444,Downregulated
Feature0072,Pyruvic acid,C3 H4 O3,88.01606,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Carbon metabolism;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant hormones;Ascorbate and aldarate metabolism;Biosynthesis of terpenoids and steroids;Glucagon signaling pathway;Central carbon metabolism in cancer;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of microbial D-galacturonate and D-glucuronate degradation;Homolactic fermentation;Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of L-threonine metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of coenzyme A biosynthesis II (plants);Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of chorismate metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of L-lysine degradation;Other,Pyruvic acid,3,4,0,3,0,0,0,0,1.3333333333333333,1,0.6666666666666665,41.3,2,-1,-Inf,0.3333333333333333,-1,Tannin,2260856.8781762933,3982375.3424238735,1.7614451320935594,0.8167595364909132,0.06331185983043625,0.21105674716046818,Upregulated
Feature0071,Phenylpyruvic acid,C9 H8 O3,164.04728,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of chorismate metabolism;Other,Phenylpyruvic acid,9,8,0,3,0,0,0,0,0.8888888888888888,0.3333333333333333,-0.22222222222222232,66.63333333333333,6,3,0.5,0.6,3,Lignin,1391218.8248655987,344599.96372305235,0.24769644973452906,-2.013354904490795,0.20036029133502875,0.35949979306502305,Downregulated
Feature0070,2-isopropylmaleic acid,C7 H10 O4,158.05784,Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis,2-isopropylmaleic acid,7,10,0,4,0,0,0,0,1.4285714285714286,0.5714285714285714,-0.2857142857142856,68.44285714285714,3,-1,-0.3333333333333333,0.2,-1,Lignin,13419918.653897267,10534521.697305787,0.7849914719301571,-0.3492511140944378,0.2061868800429118,0.3597750661973257,Downregulated
Feature0069,L-Serine,C3 H7 N O3,105.04262,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Carbon metabolism;Biosynthesis of amino acids;Central carbon metabolism in cancer;Other,Methanobacterium thermoautotrophicumÂ biosynthetic metabolism;Superpathway of chorismate metabolism;Other,L-Serine,3,7,1,3,0,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,7681765.901243486,11273970.391114324,1.4676274356771728,0.5534857795447147,0.09360874385761185,0.25931792540325765,Upregulated
Feature0068,NA,C8 H21 N8 O8 P,388.12197,NA,NA,Feature0068,8,21,8,8,0,1,0,0,2.625,1,1.75,10.424999999999995,3,-5,1.5555555555555556,2,-14,Other,162657840.30593303,108330776.18942626,0.6660040240647093,-0.5863972006528947,0.5289288620148284,0.630291535920109,Downregulated
Feature0067,Propylparaben,C10 H12 O3,180.07863,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,NA,Propylparaben,10,12,0,3,0,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,20163440.139977433,9734633.99101286,0.4827863659888225,-1.050543160298259,0.026953129087077875,0.16912126459608967,Downregulated
Feature0066,NA,C19 H32 O3 S,340.20729,NA,NA,Feature0066,19,32,0,3,1,0,0,0,1.6842105263157894,0.15789473684210523,-1.2631578947368425,96.3,4,1,0,0.09090909090909093,0,Lipid,1576007.23338725,1925889.4994197567,1.222005495038572,0.28925077259287235,0.633397586371933,0.736639492760265,Upregulated
Feature0065,3-Hydroxyvaleric acid,C5 H10 O3,118.06304,Metabolic pathways;Other,NA,3-Hydroxyvaleric acid,5,10,0,3,0,0,0,0,2,0.6,-0.7999999999999998,83.1,1,-2,-1,-0.14285714285714285,-2,Amino Sugar,6242797.071589479,195801.17432076402,0.03136433430005936,-4.994731247632856,0.1771007535318117,0.34471932508735253,Downregulated
Feature0064,D-Glucopyranuronic acid,C6 H10 O7,194.04263,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of cofactors;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,D-Glucopyranuronic acid,6,10,0,7,0,0,0,0,1.6666666666666667,1.1666666666666667,0.6666666666666665,41.3,2,-5,5,-0.6,-5,Carbohydrate,872410.007821504,729527.766759838,0.8362212265097033,-0.258043429893722,0.6662244240398307,0.7671675185913203,Downregulated
Feature0063,APM,C7 H13 N O4,175.08439,NA,NA,APM,7,13,1,4,0,0,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,188207.193992719,247689.48871775565,1.3160468708084443,0.39621087135183813,0.1289832458010729,0.2998557752594217,Upregulated
Feature0062,D-Glucono-delta-lactone,C6 H10 O6,178.04772,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Galactose metabolism;Carbon metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of microbial D-galacturonate and D-glucuronate degradation;Other,D-Glucono-delta-lactone-peak1,6,10,0,6,0,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,7156938.13773031,4467583.37779434,0.6242311015994266,-0.679847855212045,0.4360904180510606,0.5475958867974121,Downregulated
Feature0061,NA,C3 H9 N7 O11,319.03608,NA,NA,Feature0061,3,9,7,11,0,0,0,0,3,3.6666666666666665,11.333333333333332,-262.69999999999993,3,-8,1,1,-15,Other,434348.267223633,106769.09718070757,0.2458144885973157,-2.024358142514982,0.17503653157993965,0.34471932508735253,Downregulated
Feature0060,NA,C9 H18 O10,286.09013,NA,NA,Feature0060,9,18,0,10,0,0,0,0,2,1.1111111111111112,0.22222222222222232,53.96666666666666,1,-9,9,-1,-9,Carbohydrate,110584.1752668414,196002.604984083,1.7724290524491915,0.8257278798042803,0.02620295016919937,0.16912126459608967,Upregulated
Feature0059,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03784,NA,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Lignin,456531.83840684465,717250.0337807667,1.571084365733939,0.6517606540617418,0.09943058954098863,0.26686502690663877,Upregulated
Feature0058,NA,C11 H16 N2 O7,288.09583,NA,NA,Feature0058,11,16,2,7,0,0,0,0,1.4545454545454546,0.6363636363636364,0.36363636363636376,49.93636363636363,5,-2,-2,-0.09090909090909093,-4,Lignin,18856229.6846334,18191652.472487867,0.9647555623122728,-0.051764638217543256,0.8323375165455866,0.875875171257202,Downregulated
Feature0057,NA,C17 H32 O17,508.16405,NA,NA,Feature0057,17,32,0,17,0,0,0,0,1.8823529411764703,1,0.11764705882352944,56.94705882352941,2,-15,-Inf,-0.7647058823529411,-15,Carbohydrate,70818.98501440289,124742.78897771233,1.7614314714104224,0.8167483477937006,0.041643920644069035,0.18042689182236984,Upregulated
Feature0056,NA,C7 H16 N O7 P,257.0665,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Feature0056,7,16,1,7,0,1,0,0,2.2857142857142856,1,-0.5714285714285712,76.58571428571427,1,-6,4,-3,-8,Carbohydrate,517402.802387329,484104.9288679523,0.9356441956523269,-0.09596808511821851,0.7988538546987768,0.875875171257202,Downregulated
Feature0055,"5,7-Dihydroxy-4-methylcoumarin",C10 H8 O4,192.04227,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of phenylpropanoids;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,"5,7-Dihydroxy-4-methylcoumarin",10,8,0,4,0,0,0,0,0.8,0.4,0,60.3,7,3,0.5,0.625,3,Condensed HC,68544.88451745884,65018.7240218415,0.9485569124458997,-0.07619375842484659,0.854403975630134,0.8888349830779889,Downregulated
Feature0054,Dichloroacetic acid,C2 H2 Cl2 O2,127.94324,Microbial metabolism in diverse environments;Other,NA,Dichloroacetic acid,3,2,0,2,0,0,0,2,0.6666666666666666,0.6666666666666666,0.6666666666666665,41.3,3,1,1,1,1,Condensed HC,569268.3926682957,197486.53813155668,0.34691288094512074,-1.527354685711199,0.2923466035522064,0.43095921730540765,Downregulated
Feature0053,Uridine 5'-diphosphogalactose,C15 H24 N2 O17 P2,566.05509,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Galactose metabolism;Ascorbate and aldarate metabolism;Other,Superpathway of anaerobic sucrose degradation;Superpathway of scopolin and esculin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Superpathway of betalain biosynthesis;Other,Uridine 5'-diphosphogalactose,15,24,2,17,0,2,0,0,1.6,1.1333333333333333,0.3999999999999999,48.9,6,-11,2.5,-2.6,-15,Carbohydrate,3610015.1760033835,5139285.0769091435,1.4236186903232915,0.5095627788564584,0.021538834811405838,0.16912126459608967,Upregulated
Feature0052,N-Acetylglucosaminitol,C8 H17 N O6,223.10559,NA,NA,N-Acetylglucosaminitol-peak1,8,17,1,6,0,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,1213434.4539717636,1125144.372275231,0.9272395130964468,-0.10898604867490964,0.8161036291051164,0.875875171257202,Downregulated
Feature0051,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08486,NA,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,1491774.89052579,668996.9658570373,0.44845704945552683,-1.156958275862597,0.1003322964770657,0.26686502690663877,Downregulated
Feature0050,NA,C8 H7 N3 O6 P2,302.98095,NA,NA,Feature0050,8,7,3,6,0,2,0,0,0.875,0.75,0.5,46.05,8,2,1,NA,-3,Tannin,249562.17040844468,378482.32323929365,1.516585316676211,0.6008266601668069,0.09172957829873195,0.25931792540325765,Upregulated
Feature0049,NA,C7 H12 O8,224.05313,NA,NA,Feature0049,7,12,0,8,0,0,0,0,1.7142857142857142,1.1428571428571428,0.5714285714285716,44.014285714285705,2,-6,6,-0.6666666666666666,-6,Carbohydrate,127417.3776507285,198937.43795377566,1.5613053856679986,0.6427527508316473,0.09402170394737996,0.25931792540325765,Upregulated
Feature0048,Adenosine,C10 H13 N5 O4,267.09688,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Adenosine-peak1,10,13,5,4,0,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,5796641.763101587,9338661.03526355,1.6110467779307356,0.6879983843665977,0.08759877015656804,0.2582653395995368,Upregulated
Feature0047,3797,C8 H10 O4,170.05789,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,3797,8,10,0,4,0,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Lignin,296382.93235420564,340699.01552420435,1.149523060649919,0.20103540833670622,0.6540671053104208,0.7557126689735267,Upregulated
Feature0046,Threonine,C4 H9 N O3,119.0583,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters;Biosynthesis of plant secondary metabolites;Biosynthesis of amino acids;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Threonine,4,9,1,3,0,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,6418755.47953387,8589623.530551637,1.3382070025785457,0.4203012987106252,0.13833990152214765,0.3072223787050292,Upregulated
Feature0045,NA,C11 H25 N O7,283.16316,NA,NA,Feature0045,11,25,1,7,0,0,0,0,2.272727272727273,0.6363636363636364,-0.7272727272727275,81.02727272727273,0,-7,-2.6666666666666665,-0.6923076923076923,-8,Other,109920.5084109314,164221.52959922765,1.4940026385730956,0.579182696087631,0.17499511255554692,0.34471932508735253,Upregulated
Feature0044,NA,C8 H9 N3 O5 P2,289.00169,NA,NA,Feature0044,8,9,3,5,0,2,0,0,1.125,0.625,0,60.3,7,2,1.5,-1,-3,Lignin,161801.68161395134,245178.058852615,1.515299818932627,0.5996032752112928,0.11518850031415448,0.28966519931941787,Upregulated
Feature0043,NA,C7 H7 N3 O6 P2,290.98097,NA,NA,Feature0043,7,7,3,6,0,2,0,0,1,0.8571428571428571,0.5714285714285716,44.014285714285705,7,1,1,1,-4,Tannin,149076.2013337701,264449.79128736665,1.7739235969347247,0.8269438739585503,0.030524172002024483,0.17078205932289886,Upregulated
Feature0042,NA,C19 H30 O16,514.15333,NA,NA,Feature0042,19,30,0,16,0,0,0,0,1.5789473684210529,0.8421052631578947,0.10526315789473673,57.3,5,-11,-3.6666666666666665,-0.2727272727272727,-11,Carbohydrate,98150.45178808979,177160.43527329733,1.8049884849821458,0.8519896333938066,0.027465385438350854,0.16912126459608967,Upregulated
Feature0041,NA,C16 H39 N7 O11 P2,567.2184,NA,NA,Feature0041,16,39,7,11,0,2,0,0,2.4375,0.6875,-0.375,70.9875,2,-9,4.5,-8.333333333333334,-18,Other,165456.35775947903,502938.81242376834,3.0397067796867714,1.6039321631772647,0.2642656610130369,0.40347703601097595,Upregulated
Feature0040,"Î±,Î±-Trehalose",C12 H22 O11,342.11632,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,"Î±,Î±-Trehalose-peak2",12,22,0,11,0,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,443951.517518027,493755.82460603665,1.112184112730254,0.15339563386738447,0.8226896130789206,0.875875171257202,Upregulated
Feature0039,NA,C13 H16 N7 O5 P S2,445.03926,NA,NA,Feature0039,13,16,7,5,2,1,0,0,1.2307692307692308,0.38461538461538464,1.076923076923077,29.6076923076923,10,5,2.5,-5,-5,Lignin,284008.006229539,393471.84691019997,1.3854251932327248,0.47032881383931574,0.3218266534197628,0.4605218220483635,Upregulated
Feature0038,(6-Hydroxy-1-oxo-1H-isochromen-3-yl)methyl hydrogen sulfate,C10 H8 O7 S,271.99907,Other,NA,(6-Hydroxy-1-oxo-1H-isochromen-3-yl)methyl hydrogen sulfate,10,8,0,7,1,0,0,0,0.8,0.7,0.7999999999999998,37.5,7,0,-0.5,0.4545454545454546,-1,Condensed HC,126657.35051066239,198040.767833658,1.5635947462598023,0.6448666422355799,0.20363700388811753,0.35949979306502305,Upregulated
Feature0037,NA,C16 H26 N2 O10,406.15889,NA,NA,Feature0037,16,26,2,10,0,0,0,0,1.625,0.625,0,60.3,5,-5,-1.75,-0.2222222222222222,-7,Amino Sugar,285546.4343814703,498629.2671221643,1.7462283085490398,0.8042421947510761,0.03926750106922886,0.1790598048756836,Upregulated
Feature0036,Linoleic acid,C18 H32 O2,280.24026,Metabolic pathways;Biosynthesis of plant secondary metabolites;Other,Other,Linoleic acid,18,32,0,2,0,0,0,0,1.7777777777777777,0.1111111111111111,-1.5555555555555554,104.63333333333333,3,1,0.0625,0.1176470588235294,1,Lipid,7564156.286506023,9929329.152573876,1.3126816496754796,0.3925170775999375,0.14964217289120482,0.3198601445549503,Upregulated
Feature0035,trimetaphosphoric acid,H3 O9 P3,239.89901,NA,NA,trimetaphosphoric acid,0,3,0,9,0,3,0,0,Inf,Inf,NA,NA,1,-8,0.9166666666666666,0.8666666666666667,-11,Other,9998375.850568153,19089917.669109,1.9093018660649996,0.9330452149714076,0.16298098462989966,0.3357801008640101,Upregulated
Feature0034,Monomethyl phthalate,C9 H8 O4,180.04223,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of chorismate metabolism;Other,Monomethyl phthalate,9,8,0,4,0,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,2845864.093597943,467738.2226474,0.16435718898159055,-2.6050935336242254,0.2595626250790225,0.39818254000503933,Downregulated
Feature0033,NA,C10 H6 S,158.01901,NA,NA,Feature0033,10,6,0,0,1,0,0,0,0.6,0,-0.4000000000000003,71.7,8,8,0.7777777777777778,0.7777777777777778,7,Condensed HC,354318.06251630734,657407.3868388853,1.8554159564152288,0.8917426536848587,0.15866079587084037,0.33086580602333787,Upregulated
Feature0032,3-[(2Z)-1-Oxo-2-buten-2-yl]pentanedioic acid,C9 H12 O5,200.06847,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,3-[(2Z)-1-Oxo-2-buten-2-yl]pentanedioic acid-peak1,9,12,0,5,0,0,0,0,1.3333333333333333,0.5555555555555556,-0.22222222222222232,66.63333333333333,4,-1,-0.25,0.2307692307692308,-1,Lignin,2521839.533152283,2767519.0967975203,1.09742077575338,0.1341167934706817,0.4371160148996886,0.5475958867974121,Upregulated
Feature0031,1-(beta-D-ribofuranosyl)thymine,C10 H14 N2 O6,258.08519,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,1-(beta-D-ribofuranosyl)thymine,10,14,2,6,0,0,0,0,1.4,0.6,0.3999999999999999,48.9,5,-1,-1.5,0,-3,Lignin,661973.163559154,724587.6029967463,1.0945875798060158,0.13038739161059906,0.7122487273469338,0.8092659958559845,Upregulated
Feature0030,Leucylproline,C11 H20 N2 O3,228.14735,NA,NA,Leucylproline,11,20,2,3,0,0,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,4964591.22513158,8127739.370287844,1.6371417105085886,0.7111792064787588,0.10456442781901863,0.2709169266220028,Upregulated
Feature0029,"3,4-Dihydroxyphenylpropionic acid",C9 H10 O4,182.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"3,4-Dihydroxyphenylpropionic acid",9,10,0,4,0,0,0,0,1.1111111111111112,0.4444444444444444,-0.22222222222222232,66.63333333333333,5,1,0.2,0.42857142857142855,1,Lignin,798351.885244283,735276.35719774,0.9209928238257459,-0.11873817969055946,0.8012638146354865,0.875875171257202,Downregulated
Feature0028,4-Pyridoxic acid,C8 H9 N O4,183.0532,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,4-Pyridoxic acid,8,9,1,4,0,0,0,0,1.125,0.5,0.25,53.175,5,1,0,0.4,0,Lignin,11994144.049450627,11493673.131815434,0.9582737279482552,-0.06149027864793943,0.8448148809422361,0.8849881351563296,Downregulated
Feature0027,Succinic anhydride,C4 H4 O3,100.01606,NA,NA,Succinic anhydride,4,4,0,3,0,0,0,0,1,0.75,0.5,46.05,3,0,0,0.6,0,Tannin,452024.685316069,899463.899534465,1.989855706454468,0.9926638181407201,0.3362960946157039,0.4772334620687583,Upregulated
Feature0026,"2-(Hydroxymethyl)-5-methoxy-4-methyl-1,3-benzenediol",C9 H12 O4,184.07352,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"2-(Hydroxymethyl)-5-methoxy-4-methyl-1,3-benzenediol",9,12,0,4,0,0,0,0,1.3333333333333333,0.4444444444444444,-0.44444444444444464,72.96666666666667,4,0,0,0.2857142857142857,0,Lignin,238586.11469536737,77015.91239697026,0.322801318489578,-1.6312816235378063,0.24252398665166383,0.38222674393948863,Downregulated
Feature0025,100-1,C31 H34 O10,566.21508,Biosynthesis of secondary metabolites;Other,NA,100-1,31,34,0,10,0,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Lignin,39947.64661424136,86379.27799129424,2.1623120587158686,1.112574743735882,0.060065682405074546,0.20692692931398393,Upregulated
Feature0024,2-Oxo-4-pentenoic acid,C5 H6 O3,114.03175,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,2-Oxo-4-pentenoic acid,5,6,0,3,0,0,0,0,1.2,0.6,0,60.3,3,0,0,0.42857142857142855,0,Lignin,165169.16404896133,417527.305232662,2.5278768445476527,1.3379261786699304,0.17942590850777715,0.34471932508735253,Upregulated
Feature0023,2-Hydroxycaproic acid,C6 H12 O3,132.0787,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,2-Hydroxycaproic acid,6,12,0,3,0,0,0,0,2,0.5,-1,88.8,1,-2,-0.6666666666666666,-0.1111111111111111,-2,Protein,1360142.7800437394,216938.65582788366,0.15949697267878551,-2.648399053610394,0.16936407717857688,0.34471932508735253,Downregulated
Feature0022,Caffeic acid,C9 H8 O4,180.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Degradation of aromatic compounds;Biosynthesis of amino acids;Biosynthesis of phenylpropanoids;2-Oxocarboxylic acid metabolism;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of chorismate metabolism;Other,Caffeic acid,9,8,0,4,0,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,6730256.607138936,2957832.1966960635,0.43948282648816445,-1.1861213040907823,0.023131568180846374,0.16912126459608967,Downregulated
Feature0021,NA,C6 H15 N O9,245.07472,NA,NA,Feature0021,6,15,1,9,0,0,0,0,2.5,1.5,1,31.799999999999997,0,-9,2.5,-11,-10,Carbohydrate,15278018.5398266,23287929.411422234,1.5242768131688982,0.6081249243021163,0.04190122957861499,0.18042689182236984,Upregulated
Feature0020,NA,C27 H24 N6 O8,560.16569,NA,NA,Feature0020,27,24,6,8,0,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Lignin,74139.37846306646,112197.825092813,1.5133364673229068,0.5977327844953871,0.03056561545900694,0.17078205932289886,Upregulated
Feature0019,4-Methylphenol,C7 H8 O,108.05753,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,4-Methylphenol,7,8,0,1,0,0,0,0,1.1428571428571428,0.14285714285714285,-0.8571428571428568,84.72857142857141,4,3,0.5,0.5384615384615384,3,Lignin,6513950.796750226,64098.4750957486,0.009840184105739174,-6.667098976622757,0.17960233651335733,0.34471932508735253,Downregulated
Feature0018,NA,C10 H3 N2 O4 P,245.98313,NA,NA,Feature0018,10,3,2,4,0,1,0,0,0.3,0.4,0.6000000000000001,43.2,11,7,1.3333333333333333,1.2,4,Condensed HC,1759432.9054388034,729830.6783400467,0.4148101789411666,-1.2694767983067066,0.028296594582851636,0.16912126459608967,Downregulated
Feature0017,Dimethyl phthalate,C10 H10 O4,194.058,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of phenylpropanoids;Other,Superpathway of scopolin and esculin biosynthesis;Other,Dimethyl phthalate,10,10,0,4,0,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,380273.175443353,235875.896653508,0.6202801351383909,-0.6890081724542982,0.6324584166126769,0.736639492760265,Downregulated
Feature0016,Polygonolide,C12 H12 O4,220.07345,NA,NA,Polygonolide,12,12,0,4,0,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,7,3,0.375,0.5,3,Lignin,121582.6368292343,129094.56699263267,1.0617845636457865,0.08649107264929208,0.8550488579902291,0.8888349830779889,Upregulated
Feature0015,Ethylmalonic acid,C5 H8 O4,132.04231,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of L-lysine degradation;Other,Ethylmalonic acid,5,8,0,4,0,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,3706361.7813704167,164707.93052919168,0.04443924804024161,-4.49202178478923,0.40941045976527685,0.5340653755448862,Downregulated
Feature0014,[3-(4-Methoxyphenyl)-2-oxiranyl]methyl hydrogen sulfate,C10 H12 O6 S,260.03538,NA,NA,[3-(4-Methoxyphenyl)-2-oxiranyl]methyl hydrogen sulfate,10,12,0,6,1,0,0,0,1.2,0.6,0.20000000000000015,54.599999999999994,5,-1,-0.6666666666666666,0.16666666666666666,-2,Lignin,2179723.2852171767,1069427.4490425547,0.49062532675380505,-1.0273063851683475,0.3482784421268291,0.4860161893457482,Downregulated
Feature0013,NA,C10 H16 O8,264.08464,NA,NA,Feature0013,10,16,0,8,0,0,0,0,1.6,0.8,0,60.3,3,-5,-2.5,-0.16666666666666666,-5,Carbohydrate,98950.1727687698,174422.97016785,1.762735377687997,0.8178159131428044,0.04098655985968607,0.18042689182236984,Upregulated
Feature0012,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,NA,.alpha.-Glucoheptitol-peak1,7,16,0,7,0,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,14689739.762123499,12762401.539035242,0.8687969797764717,-0.20290900701797024,0.4354755983195967,0.5475958867974121,Downregulated
Feature0011,2-Oxobutyric acid,C4 H6 O3,102.03169,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of L-lysine degradation;Other,2-Oxobutyric acid-peak2,4,6,0,3,0,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,1047539.0882326047,1409206.5627757444,1.3452543953785445,0.42787902054884347,0.42351846486413397,0.5434187541966283,Upregulated
Feature0010,2-Hydroxyvaleric acid,C5 H10 O3,118.06305,Metabolic pathways;Other,NA,2-Hydroxyvaleric acid,5,10,0,3,0,0,0,0,2,0.6,-0.7999999999999998,83.1,1,-2,-1,-0.14285714285714285,-2,Amino Sugar,2419528.4231378334,462136.83957606833,0.19100285624118984,-2.3883338825206324,0.08626494372020263,0.2565444413244287,Downregulated
Feature0009,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09471,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak1",14,16,0,6,0,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,37036.36041932603,43602.65547537583,1.1772932054258611,0.23547366900384648,0.37403928346070947,0.5104421410784786,Upregulated
Feature0008,"Î±,Î±-Trehalose",C12 H22 O11,342.11636,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Galactose metabolism;Phosphotransferase system (PTS);Other,Superpathway of anaerobic sucrose degradation;Chitin biosynthesis;Superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis;Other,"Î±,Î±-Trehalose-peak1",12,22,0,11,0,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,1282176.4167288665,1946967.2726036266,1.518486260705682,0.6026338550305944,0.036250475606109944,0.17252933836885667,Upregulated
Feature0007,Cytidine,C9 H13 N3 O5,243.08554,Metabolic pathways;ABC transporters;Other,Other,Cytidine,9,13,3,5,0,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Lignin,224524.23893976098,497309.7585355717,2.2149490891671526,1.1472735386673436,0.03733090947162396,0.17252933836885667,Upregulated
Feature0006,D-(â)-Erythrose,C4 H8 O4,120.04223,NA,NA,D-(â)-Erythrose-peak1,4,8,0,4,0,0,0,0,2,1,0,60.3,1,-3,-Inf,-0.5,-3,Carbohydrate,30115288.052689433,70749506.12396373,2.349288706791748,1.2322240186981817,0.00779289368882281,0.1599709071596444,Upregulated
Feature0005,Thymidine,C10 H14 N2 O5,242.09031,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Thymidine,10,14,2,5,0,0,0,0,1.4,0.5,0.20000000000000015,54.599999999999994,5,0,-0.6666666666666666,0.09090909090909093,-2,Lignin,47493178.23266433,47910206.442120336,1.008780802316767,0.012612725717376337,0.9589729804382958,0.9732010662014753,Upregulated
Feature0004,2-Oxobutyric acid,C4 H6 O3,102.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Carbon metabolism;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of L-lysine degradation;Other,2-Oxobutyric acid-peak1,4,6,0,3,0,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,1019149.900093099,1879491.3565215967,1.8441755784403313,0.882976016985532,0.05544453790071205,0.1989261788103176,Upregulated
Feature0003,NA,C9 H16 O7,236.0896,NA,NA,Feature0003,9,16,0,7,0,0,0,0,1.7777777777777777,0.7777777777777778,-0.22222222222222232,66.63333333333333,2,-5,-2.5,-0.2727272727272727,-5,Carbohydrate,47819548.280713744,1007114.0987666986,0.021060719621495902,-5.569301457274994,0.18865509266334424,0.3525685338298565,Downregulated
Feature0002,L-Iditol,C6 H14 O6,182.079,Metabolic pathways;ABC transporters;Galactose metabolism;Fructose and mannose metabolism;Phosphotransferase system (PTS);Other,Other,L-Iditol-peak1,6,14,0,6,0,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,2219348.940644418,956303.7459684697,0.4308938213613196,-1.2145956832696354,0.33394980690750337,0.4758784748431923,Downregulated
Feature0001,"L-Fucono-1,5-lactone",C6 H10 O5,162.05279,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Fructose and mannose metabolism;Other,Superpathway of butirocin biosynthesis;Other,"L-Fucono-1,5-lactone",6,10,0,5,0,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,11276697.812804254,6852544.472681084,0.6076729718606351,-0.7186329699120559,0.134529461687262,0.3007129143597621,Downregulated
